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Abstract
Stromal-interaction molecule 2 (STIM2) is an endoplasmic reticulum (ER) membrane-inserted
Ca2+-sensing protein which, together with the plasma membrane Ca2+ channel Orai1, regulates
basal Ca2+ homeostasis and store-operated Ca2+ entry (SOCE). Recent evidence suggests that Snitrosylation, which is the covalent attachment of a nitric oxide (NO) moiety to a cysteine thiol,
can attenuate the function of the paralog STIM1 protein. Compared to STIM1, STIM2 also
functions as a basal Ca2+ homeostatic feedback regulator. Therefore, the objective of my study was
to evaluate the susceptibility of STIM2 to S-nitrosylation and the effects that this modification has
on basal Ca2+ homeostasis, which is uniquely controlled by STIM2, as well as SOCE, which is
regulated by both STIM1 and STIM2. Recombinant wildtype and Cys-mutated human STIM2
Ca2+ sensing luminal domain proteins were treated with either excess NO donor, Snitrosoglutathione (GSNO), to promote S-nitrosylation or dithiolthreitol (DTT), to maintain
reduced sulfhydryls as controls, to determine the effect of S-nitrosylation on the biophysical
properties of the domain. Fura-2-AM ratiometric fluorimetry was used to probe basal Ca2+ and
SOCE in mammalian HEK293T cells transiently co-overexpressing enhanced green fluorescent
protein fused to Orai1 (i.e. eGFP-Orai1) and mCherry tagged full length STIM2 (i.e. mChSTIM2)
variants in the presence or absence of excess NO. My data revealed that excess NO thermally and
thermodynamically stabilized the full luminal domain of STIM2 in a Cys-dependent manner.
Structurally, I found that excess NO alters the structure of the highly conserved core Ca2+ sensing
region of STIM2 despite the S-nitrosylation sites being far in sequence space. Moreover, my data
suggest that all three modifiable Cys sulfhydryls within the variable N-terminal region of STIM2
can contribute to enhanced luminal domain stabilization in the presence of excess NO. Consistent
with the observed stabilization in vitro, I found that the basal Ca2+ and SOCE regulating function
of STIM2 was suppressed in the full-length molecular context when live cells were exposed to
exogenous NO. Taken together, this study reveals novel molecular insights into S-nitrosylationmediated regulation of STIM2 structure and function via NO exposure, and is a first step towards
understanding the complex role that NO may play in the regulation of cellular Ca2+.
Keywords:
Stromal interaction molecule 2, nitric oxide, post-translational modifications, S-nitrosylation,
store-operated calcium entry, basal calcium homeostasis
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Layman Abstract
Stromal-interaction molecule 2 (STIM2) is a calcium (Ca2+) sensing protein embedded within the
endoplasmic reticulum (ER) membrane of cells. Upon ER luminal Ca2+ depletion, which can result
from myriad physiological and pathological cellular signals, STIM2 becomes activated, and
together with Orai1, a plasma membrane bound Ca2+ channel, can form Ca2+ release activated Ca2+
(CRAC) channels to elicit the influx of extracellular Ca2+ into the cytosol of cells, otherwise known
as store operated Ca2+ entry (SOCE). Inappropriate activation of SOCE can lead to a wide range
of pathologies, including neurodegeneration, heart muscle cell enlargement, and a weakened
immune system. Recent evidence suggests that S-nitrosylation, or the covalent attachment of a
nitric oxide (NO) moiety to cysteine residues, can suppress the function of Ca2+-sensing proteins.
Therefore, the objective of my study was to evaluate the susceptibility of STIM2 to S-nitrosylation
and the downstream structural mechanism by which this modification can affect function. By
utilizing S-nitrosoglutathione treatment, a chemical which can sufficiently S-nitrosylate proteins,
and a wide range of spectroscopic techniques, my data elucidated the structural mechanism by
which S-nitrosylation stabilizes the luminal region of STIM2 to suppress its function as a mediator
of SOCE within mammalian cells. This study reveals novel molecular insights into S-nitrosylationmediated regulation of STIM2 structure and function via NO exposure, and is a first step towards
understanding the complex role that NO may play in the regulation of cellular Ca2+ to treat a wide
range of pathologies.
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Chapter 1: Introduction
1.1

Overview

The importance of tightly regulating basal calcium (Ca2+) levels is evident through myriad
pathologies with dysregulated Ca2+ homeostasis, including neurodegenerative diseases, muscular
dystrophies, and cardiovascular abnormalities (Davlouros et al., 2016; Mattson, 2007; VallejoIllarramendi et al., 2014). Stromal-interaction molecules (STIM)1 and 2 are endoplasmic reticulum
(ER) membrane-inserted Ca2+ sensors that respond to fluctuations in ER luminal Ca2+ levels
(Williams et al., 2001). Upon ER Ca2+ store depletion, STIMs become activated, which causes
downstream initiation of store-operated Ca2+ entry (SOCE) and triggers an influx of Ca2+ into the
cytosol (Roos et al., 2005; Zhang et al., 2005a). Dysregulation of SOCE can lead to perturbations
of intracellular Ca2+ signalling and homeostasis, thus contributing to a multitude of disease states
(Shaw and Feske, 2012).
Nitric oxide (NO) is a chemical compound involved in the regulation of the nervous, immune, and
cardiovascular systems and is endogenously produced in the body by a family of enzymes termed
nitric oxide synthases (NOS). Specifically, NOS can regulate the structure and function of Ca2+
binding proteins through the process of S-nitrosylation, or the covalent addition of a NO moiety to
a reduced Cys residue to form S-nitrosocysteines (Gonzalez et al., 2007; Irie et al., 2015). Recent
evidence suggests that S-nitrosylation can stabilize the luminal Ca2+ sensing domain of STIM1,
thereby suppressing Ca2+ sensitivity and inhibiting SOCE activation (Gui et al., 2018; Zhu et al.,
2018). While STIM1 predominately mediates larger and transient influx of Ca2+ into the cytosol,
STIM2 mediates smaller and sustained influx (Stathopulos et al., 2009; Zheng et al., 2008). As a
result, STIM2 has an additional and unique role of regulating basal Ca2+ homeostasis (Brandman
et al., 2007). Although post-translational modifications which regulate STIM1 function have been
extensively studied, little is known about how post-translational modifications affect STIM2
(Novello et al., 2018). Thus, the objective of my study was to determine if STIM2 is also
susceptible to S-nitrosylation and the potential effects that this modification may have on basal
Ca2+ homeostasis and SOCE regulation.
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1.2

Calcium

1.2.1 General functions of Ca2+
Calcium ions (Ca2+) are a universal signalling ion essential for life. With more than 99% of Ca2+
in the human body immobilized in bone, it may seem unlikely that Ca2+ plays such an important
role in maintaining homeostasis. Despite the small percentage of ionized Ca2+ in solution, by
interacting with proteins and affecting electrochemical environments, Ca2+ is involved in a myriad
of physiological processes including neuronal activity, apoptosis, muscle contractions, immune
responses, and enzyme kinetics and activation (Cheng et al., 1993; Ebashi and Endo, 1968; Ghosh
and Greenberg, 1995; Kikkawa et al., 1983; Orrenius et al., 2003; Walleczek, 1992).
From the moment cellular life begins to the time it ends, Ca2+ is intimately involved in cellular
processes. During conception, the binding of a spermatozoa to an oocyte induces intracellular free
Ca2+ oscillations to promote embryonic development mediated by upregulated transcription factors
(Santella et al., 2004; Taylor et al., 1993). As development progresses, the initiation of localized
intercellular Ca2+ signalling leads to an increase in embryonic cell number and contributes to the
formation of the fetus (Poenie et al., 1985). On the opposite spectrum of cellular life, Ca2+ plays
an important role in cell death. During cellular stress and injury, Ca2+ released after mitochondria
Ca2+ overload can initiate pro-apoptotic signalling cascades which ultimately lead to programmed
cell death (Mattson and Chan, 2003). Similarly, in cellular states where mitochondrial energy
metabolism is altered, elevated intracellular Ca2+ levels cause widespread activation of various
Ca2+-dependent catabolic enzymes leading to necrosis (Orrenius et al., 2015).
Physiologic changes in Ca2+ levels are also implicated in the human immune system. Specifically,
elevations in cytosolic Ca2+ can activate calcineurin, a calcium dependent protein phosphatase,
which aids in positive selection during immature T-cell (thymocyte) development (Bueno et al.,
2002). Disturbing the catalytic and regulatory subunits of calcineurin results in fewer positive
thymocytes, or a reduction in positive selection (Neilson et al., 2004). Once matured, the binding
of an antigen triggers elevated intracellular Ca2+ levels which activates T-cells. This elevation is
mediated by phospholipase C-g (PLC) (van Leeuwen and Samelson, 1999), which i) activates
protein kinase C and Ras-dependent pathways, causing an influx of Ca2+ from the extracellular
space and ii) produces 1,4,5-inositol trisphosphate (IP3), causing an influx of Ca2+ into the cytosol
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from the ER. In order to efficiently activate T-cells to produce pro-inflammatory cytokines, a
sustained Ca2+ response is required (Negulescu et al., 1994). This event is facilitated by elevated
cytosolic Ca2+ levels, which can trigger the opening of Ca2+ release activated Ca2+ (CRAC)
channels, allowing additional Ca2+ to flow into the cytosol (Cahalan and Chandy, 2009). The
elevated cytosolic Ca2+ can then bind calmodulin, which can activate the nuclear factor of activated
T-cells (NFAT) transcription factor, thus promoting long-term proliferation and maturation of
activated T-cells (Macian, 2005).
Ca2+ also plays a major role in excitable and non-excitable cells, whereby ER membrane bound
Ryanodine receptors (RyR) and IP3 receptors (IP3R) serve as the predominant channels that
augment cytosolic Ca2+ levels from intracellular stores. Both structurally related channels regulate
Ca2+ signals that mediate numerous cellular processes. For example, RyRs regulate excitationcontraction coupling in excitable skeletal muscle cells, while IP3Rs regulate exocrine secretion in
glandular cells (Berridge et al., 2003; Mikoshiba, 2007). It is important to note, however, that there
are many pathways wherein RyRs and IP3Rs are implicated in both physiological and pathological
processes, which are not discussed here. Moreover, these previously mentioned pathways and
processes are a small minority in which Ca2+ plays an important regulatory role.

1.2.2 Cellular Ca2+ homeostasis
As evident from the aforementioned pathways, it is essential to regulate cytosolic Ca2+
homeostasis. While specific concentrations vary slightly between cells, Ca2+ is effectively
compartmentalized in the extracellular space (i.e. ~ 1 mM) with a concentration that is 10,000´
higher than the resting cytosolic concentration (i.e. ~ 0.0001 mM). In order to establish this
gradient, Plasma Membrane Ca2+-activated ATPases (PMCAs) are involved, which causes an
efflux of cytosolic Ca2+ into the extracellular space. Because of the sizeable difference in Ca2+
concentration, this efflux works against an electrical gradient created across the plasma membrane.
As a result, many cells have additional Ca2+ efflux pumps, such as the Na+-Ca2+ Exchanger (NCX),
to remedy the electrical gradient and further regulate intracellular Ca2+ levels. Together, the PMCA
and the NCX play important roles in the regulation of intracellular basal Ca2+ concentrations after
a cell stimulus has occurred. Specifically, the high affinity, low capacity PMCA is efficient at
removing intracellular Ca2+ when levels are low, thus preventing background ‘noise’ in Ca2+
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signalling cascades (Burette and Weinberg, 2007). On the other hand, the low affinity, high
capacity NCX is efficient at removing large concentrations of Ca2+ quickly, thus enabling rapid
and successive Ca2+ signalling, such as that seen in neurons (DiPolo and Beauge, 2006).
In addition to the extracellular space, Ca2+ is also segregated within intracellular stores. Under
basal conditions, Ca2+ levels within the cytosol are similar to the mitochondria. Conversely, in
times of cellular stress and injury, mitochondria can act as temporary Ca2+ stores in order to prevent
cytosolic Ca2+ overload (Pinton et al., 2008; Rimessi et al., 2008). Consequently, mitochondrial
Ca2+ concentration increases temporarily (~ 0.05 mM). Persistently high levels of mitochondrial
Ca2+ generate reactive oxygen species and subsequently lead to oxidative stress, a key determinant
in chronic heart failure (Peng and Jou, 2010; Santulli et al., 2015). To prevent this, Ca2+ is quickly
extruded from the mitochondria through a number of channels such as the Leucine-zipper EF-hand
containing Transmembrane protein-1 (LETM1) (Boyman et al., 2013; Lin and Stathopulos, 2019).
Interestingly, the Golgi apparatus (Surroca and Wolff, 2000) and peroxisomes (Lasorsa et al.,
2008) have also been shown to transiently store cytosolic Ca2+ in mammalian cells (~ 0.03 and ~
0.1 mM, respectively). Finally, the largest intracellular organellar Ca2+ store is the ER (~ 0.4 – 0.7
mM). ER Ca2+ can be released into the cytosol in a process that is mediated by a plethora of
electrochemical signals, for regulation of numerous cell functions, ranging from rapid striated
muscle contraction to long-term gene regulation.
Because intracellular Ca2+ stores are limited, extracellular Ca2+ is critical for the activation of Ca2+dependent signalling cascades, which require more chronic elevations in cytosolic Ca2+. The rise
in cytosolic Ca2+ from intracellular stores, in concert with specific molecular signals, causes
extracellular influx of Ca2+ and amplifies cytosolic Ca2+ levels. This process is termed store
operated Ca2+ entry (SOCE) (Putney, 1986). In turn, these elevated Ca2+ levels can activate Ca2+dependent processes and replenish depleted intracellular Ca2+ stores, such as those within the ER,
mitochondria, and Golgi apparatus.
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1.3

SOCE and CRAC channels

Store operated Ca2+ entry (SOCE) is a highly conserved Ca2+ signalling mechanism, present in
organisms ranging from lower eukaryotes such as Caenorhabditis elegans to higher vertebrates
such as Homo sapiens (Cai, 2007; Yeromin et al., 2004). This concept of SOCE, first described in
1986, states that agonist-induced release of intracellular Ca2+ stores results in the influx of
extracellular Ca2+ into the cytosol (Putney, 1986). The first of two essential components within
this process is a single-pass transmembrane protein inserted within the ER membrane called
Stromal Interaction Molecule (STIM), (Manji et al., 2000; Williams et al., 2001), which
structurally responds to fluctuations in ER Ca2+ levels (Liou et al., 2005; Roos et al., 2005). The
second essential component is Orai, a pore forming plasma membrane inserted protein (Prakriya
et al., 2006). Together, STIM and Orai form the highly selective CRAC channel, which facilitates
SOCE.
SOCE activation occurs after various types of cell stimulations. An initial stimulation of plasma
membrane receptors, including G-protein-coupled receptors (GPCRs), receptor tyrosine kinases
(RTKs), and T-cell receptors can lead to the production of a secondary messenger which triggers
intracellular Ca2+ store depletion. One such mechanism is the binding of endothelin 1 (ET-1) to
GPCRs in response to oxidative stress (Kahler et al., 2001; Kahler et al., 2000; Romero et al.,
2009). Upon GPCR activation, the Gq subunit can activate PLC, which causes the catalytic
cleavage of membrane bound phosphoinositide bisphosphate (PIP2) into IP3. Subsequently, IP3
triggers ER Ca2+ store depletion by binding to IP3 receptors (IP3R) on the ER membrane. Because
ER Ca2+ stores are limited, extracellular Ca2+ entry is necessary to sufficiently elevate and sustain
cytosolic Ca2+ (Venkatachalam et al., 2002). The initial depletion of ER Ca2+ by IP3-induced
opening of IP3R triggers the formation and opening of CRAC channels, causing extracellular Ca2+
entry into the cytosol (Fig. 1.1). The elevated Ca2+ levels effectively activate downstream signaling
cascades and refill the depleted ER Ca2+ store through the sarco/endoplasmic reticulum Ca2+
transport ATPase (SERCA) pump. In general, the cytosolic Ca2+ increase mediated by STIM/Oraiconstituted CRAC channels is more sustained and of a relatively lower capacity compared to
cytosolic Ca2+ increases mediated by voltage- and mechanically-gated Ca2+ channels.

5

One of the major cell signaling outcomes mediated by SOCE is transcriptional regulation through
the activation of various transcription factors such as Octamer-binding transcription factor 4 (Oct4), cAMP Response Element Binding (CREB) protein and the Nuclear Factor of Activated T-cells
(NFAT) protein (Hu et al., 2011; Hunton et al., 2002; Oh-hora and Rao, 2009; Pulver et al., 2004).
However, SOCE is also implicated in numerous other physiological and pathological processes,
including, but not limited to, the proliferation and activation of lymphocytes, the steering of
developing growth cones in response to guidance cues, the maturation of spermatocytes, and the
metastasis of neoplasms after remodeling of the tumor microenvironment [(Davis et al., 2016; Mo
and Yang, 2018; Pavez et al., 2019; Zhou et al., 2014) for a comprehensive review, see (Putney et
al., 2017)].
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1.4

Stromal Interaction Molecule and Orai proteins

In all mammalian cells, SOCE is as an essential molecular pathway mediating cytosolic Ca2+ entry
(Putney, 1986; Soboloff et al., 2006). As previously mentioned, STIM and Orai proteins are
mediators of SOCE. In Homo sapiens, two STIM homologs exist: Stromal interaction molecule 1
(STIM1) and 2 (STIM2). Upon activation by ER Ca2+ depletion, human STIM1 undergoes
structural changes which promote oligomerization and translocation to ER/PM junctions (Baba et
al., 2006; Liou et al., 2007; Luik et al., 2006; Stathopulos and Ikura, 2013a). At these junctions,
STIM1 interacts with and traps Orai1 proteins, forming CRAC channels. The direct interaction of
STIM1 with Orai1 channels also facilitates gating of the CRAC channels to induce SOCE (Feske
et al., 2006; Prakriya et al., 2006; Yeromin et al., 2006).
The human STIM2 paralog similarly regulates SOCE; however, STIM2 is less efficient than
STIM1 in this cellular role. Instead, STIM2 is more closely involved in the regulation of basal
Ca2+ homeostasis compared to STIM1 (Brandman et al., 2007). It is interesting to note that, in
lower order eukaryotes such as Drosophila melanogaster and Caenorhabditis elegans, only one
isoform of STIM exists. Thus, a molecular divergence of the STIM homolog occurred at some
point during higher order eukaryotic evolution, suggesting a distinct function for STIM2 (Cai,
2007).
Orai proteins are the plasma membrane pore-forming components which mediate SOCE via
CRAC channels. Three Orai homologs exists in humans: Orai1, Orai2, and Orai3. While all Orai
components may be activated by exogenous STIM expression, only Orai1 is responsible for
generating endogenous homomeric CRAC channel currents which underlie SOCE activation
(Frischauf et al., 2009; Lis et al., 2007). On the other hand, Orai2 and Orai3 are mainly modulators
of the predominately STIM1/Orai1 mediated Ca2+ channel currents (Hoth and Niemeyer, 2013).
However, Orai3 channels appear to differ from Orai1 and Orai2 as they are slightly resistant to the
process of Ca2+ de-potentiation (DeHaven et al., 2007).
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1.4.1 STIM organization
Human STIM1 can be translated into two isoforms, including 685 (i.e. STIM1) or 791 (i.e.
STIM1L) amino acid polypeptides, whereas its paralog, STIM2, is translated into three isoforms,
including 746 (i.e. STIM2 or STIM2.2), 754 (i.e. STIM2b or STIM2.1), and 841 (i.e. preSTIM2)
amino acid polypeptides (Fig. 1.2). Interestingly, all three STIM2 isoforms share the same core
architecture, which is similarly conserved with STIM1 isoforms.
The luminal region of STIMs (i.e. residing within the ER lumen) contains an ER targeting signal
peptide (SP) sequence, an N-terminal region that is not conserved among phylogeny as well as
canonical and non-canonical EF-hand motifs, and a sterile a-motif (SAM) domain that are
conserved in STIMs from higher- to lower-order organisms (Fig. 1.3A). While there are no known
modifications to the ER SP of STIM1, inefficient SP cleavage generates a cytosolic subpopulation
of STIM2 which is not targeted to the ER (i.e. 841 amino acid isoform) and results in ineffective
activation of Orai1 in a store-independent manner (Graham et al., 2011). As mentioned, the Nterminal region is highly variable among eukaryotes and between the human STIM homologs
(Stathopulos and Ikura, 2009; Zhou et al., 2009). Despite the high variability, the short N-terminal
regions of STIM1 and STIM2 can profoundly affect Orai1 channel activation kinetics (Zhou et al.,
2009). Interestingly, two cysteine residues within this region are conserved between STIM1 (i.e.
Cys49 and Cys56) and STIM2 (i.e. Cys53 and Cys60) (Fig. 1.3B), and post-translational
modifications to these cysteines in STIM1 affect structure and function (Choi et al., 2017b; Gui et
al., 2018; Zhu et al., 2018). It is important to note that STIM2 contains an additional modifiable
cysteine residue (i.e. Cys15) within its variable N-terminal region. However, post-translational
modifications that affect STIM2 structure and function have yet to be explored in any capacity
(Novello et al., 2018).
The EF-hand, together with the SAM domain (EFSAM), constitute the Ca2+ sensing domain of
STIMs. While it was initially proposed that STIMs only contained one EF-hand motif based on
primary structure analysis, a high-resolution structure of STIM1 EFSAM revealed a second, noncanonical EF-hand (Stathopulos et al., 2008b). Interestingly, only the canonical EF-hand
coordinates Ca2+, where it can bind one Ca2+ ion (Stathopulos et al., 2006; Stathopulos et al.,
2008b; Zheng et al., 2011b). However, a recent calorimetric analysis and competition study
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suggests as many as 5 Ca2+ binding sites may exist on STIM1 EFSAM, and up to 15 binding sites
on STIM2 EFSAM [(Gudlur et al., 2018) reviewed by (Stathopulos and Ikura, 2019)]. The second
non-canonical EF-hand exerts structurally stabilizing effects on the canonical EF-hand through
hydrogen bonding (Stathopulos et al., 2008b). As a result of its essential role in stabilizing the
canonical EF-hand, the non-canonical EF-hand is structurally conserved between STIM homologs
despite the fact that it cannot measurably coordinate Ca2+ ions. In the presence of Ca2+, the EFhands adopt an “open” or “exposed” conformation where the two helices composing each EF-hand
motif are in a semi-perpendicular conformation (Stathopulos et al., 2008b; Zheng et al., 2008). The
open conformation exposes several hydrophobic residues that mediate interactions with the SAM
domain. Thus, in the presence of Ca2+, the EF-hand and SAM domains closely interact (i.e.
EFSAM). In contrast, Ca2+ ion dissociation elicits a marked destabilization of the EFSAM domain
interaction, ultimately resulting in the oligomerization of the full luminal region (Liou et al., 2007;
Spassova et al., 2006a; Stathopulos et al., 2006; Stathopulos et al., 2013).
Despite the highly conserved EFSAM sequence between STIM homologs, the EFSAM domain of
STIM2 is more structurally stable; however, STIM2 EFSAM has a weaker apparent Ca2+ binding
affinity [Equilibrium dissociation constant (Kd) = ~0.4-0.8 mM] compared to STIM1 EFSAM (Kd
= ~0.2-0.6 mM) (Stathopulos et al., 2006; Zheng et al., 2008; Zheng et al., 2011a). Given the
resting ER lumen Ca2+ concentration (~0.4-0.7 mM) and the weaker apparent Ca2+ binding affinity,
a larger subset of STIM2 molecules are partially active at resting ER Ca2+ levels, resulting in weak
activation of Orai1 channels even in the absence of cell stimulation (Brandman et al., 2007;
Miederer et al., 2015; Rana et al., 2015; Wang et al., 2014; Zheng et al., 2018). Thus, the ability
of STIM2 to activate Orai1 under resting conditions suggests that STIM2 plays an important
physiological role in maintaining basal Ca2+ homeostasis via a feedback mechanism dependent on
ER luminal Ca2+ levels.
As previously mentioned, STIMs contain an ER-inserted, single pass transmembrane domain.
While many factors contribute to the differing activation kinetics of STIM proteins, recent
evidence suggests that differences between the transmembrane domains of STIM homologs are
involved (Zheng et al., 2018). Previous research has shown that, when the transmembrane domain
of STIM1 is swapped with that of STIM2 in the absence of Ca2+, the chimeric STIM1 protein
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harbouring the STIM2 transmembrane domain transduces the Ca2+ depletion signal across the ER
membrane to the cytosolic portion more slowly and less efficiently (Zheng et al., 2018). While not
specifically determined, it is likely that two hydrophobic residues within STIM2, but not present
in the STIM1 transmembrane domain, account for these differences.
The cytosolic regions of STIMs contain three coiled-coil (CC) domains, an inhibitory domain (ID)
and two distally located Pro/Ser and Lys-rich domains (i.e. closest to the C-terminus) (Fig. 1.2).
Previous studies indicate that the cytosolic region of STIMs can induce SOCE independently of
the luminal Ca2+ sensing region (Kawasaki et al., 2009; Park et al., 2009; Yuan et al., 2009). Thus,
the cytosolic domains contain all the molecular machinery needed to trigger Orai1-mediated SOCE
activation. Located within the cytosolic region of STIM is the Orai-activating STIM fragment
(OASF), which includes all three CC domains (i.e. CC1, CC2, and CC3). Furthermore, within the
OASF is the STIM-Orai activating region [SOAR (also known as the CRAC-activating domain
(CAD)], which includes the CC2 and CC3 domains. In the absence of ER Ca2+ depletion,
CAD/SOAR are able to maximally elicit Orai1-mediated CRAC channel currents, making CC2CC3 the minimal required domains needed to activate SOCE (Park et al., 2009; Yuan et al., 2009).
Specifically, the CC2 region can directly interact with Orai1 in order to gate STIM/Orai1 mediated
CRAC channels (Stathopulos et al., 2013). In addition to differences in the short N-terminal
regions, EFSAM stability, and TM domains between STIM homologs, differences between
CAD/SOAR amino acid sequences have also been demonstrated to regulate their distinct kinetics
of activation, further supporting the notion that STIM1 functions as a more robust activator of
Orai1 mediated CRAC channels (Brandman et al., 2007; Wang et al., 2014).
Interestingly, a STIM2 splice variant that retains exon 9 includes an additional 8 amino acids (i.e.
VAASYLIQ) within the CC2 domain (i.e. STIM2b/STIM2.1; 754 amino acid isoform), negatively
regulates Orai1 mediated SOCE (Miederer et al., 2015; Rana et al., 2015). Furthermore,
incorporation of the STIM2b 8-amino-acid insert into full-length STIM1 protein abolished the
robust SOCE response observed with wildtype STIM1 (Chung et al., 2018). These findings further
support the role of STIM2 as a basal Ca2+ homeostatic feedback regulator, wherein non-functional
STIM2b can heterodimerize with functional STIM2 (i.e. STIM2/STIM2b), thus impairing
interactions with Orai1 and subsequently modulating Ca2+ homeostasis (Miederer et al., 2015). In
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contrast, the CC1 domain has opposite effects to those of the CAD and SOAR domains. When
OASF and CC1 domains were co-expressed, Orai1 channel activity was inhibited (Fahrner et al.,
2014). Additionally, the crystal structure of a STIM1 CC1 domain fragment (i.e. residues 237 –
310) illustrates that this region can form a long and extended helix (~13 nm), likely bridging the
physical distance between the ER and PM membranes (Calloway et al., 2011; Cui et al., 2013).
Therefore, the CC2 and CC3 domains of STIMs are required for the activation of Orai1. On the
other hand, the CC1 domain is required to maintain the OASF region in a quiescent state when
STIMs are inactive, but bring the cytosolic portion of STIMs in close proximity to membranebound Orai1 once activated. Downstream from the three CC domains is the acidic inhibitory
domain (ID), which quickly inactivates STIM1-activated Orai1 channels in a Ca2+-dependent
manner (Derler et al., 2009) as well as a proline-serine rich region which can extensively undergo
post-translational modifications (see section 1.6) to differentially regulate Ca2+ flux.
Finally, the polybasic lysine-rich region is located at the C-terminus and tethers STIMs to PM
bound lipids (i.e. PIP2) to stabilize STIMs at ER/PM junctions. Interestingly, studies have shown
that deleting this region perturbs the interaction of STIM1 with the PM (Calloway et al., 2011;
Stathopulos et al., 2013) and attenuates puncta formation (Barr et al., 2009) and SOCE activation
(Jardin et al., 2013). It is worth noting that the polybasic region of STIM2 has a stronger affinity
for acidic PM bound lipids than that of STIM1 (Bhardwaj et al., 2013), likely due to the additional
basic Lys residues within this region. Taken together, these results suggest that, through multiple
different types of biomolecular interactions, the cytosolic region regulates the activation state of
STIMs and Orai channel activity.
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A.

Signal Peptide

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MNAA-------ASRA---------SRAAGEGSGSTPG
MRKNTIWNYSLIFFCCVLKSISTLDHGPHTVSVDSNRHNTQHQYKQNPNVASQRHSSHES
------------------------------------------------------------

0
0
0
21
60
0

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

------------------------------------MDVCVRLALWL---LWGPLLHQ----------------------------------------------ML---VLGLLVAGAA
---------------------------------------------ML---VLGLLVAGAA
GSPLPRRPGPGQLAVSEWPAAPVSAPPAVAPGRASGRPLRRRWAAML---LFGLLVAGVA
GQSLHNSQS-----------EHVTHIAASH--AGSGGEHSTHLAQNLHRSSYNLLSEAMS
-------------------------------------MGRVSWIIAL---YLTINVVIVV
*

19
12
12
78
107
20

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

-GQSLS--HSHSEKATGTS--------SGANSEESTAAEFCRIDKPLCHS--EDEKLSFE
DGCELVPRHLRGRRATGSAATAASSPAAAAGDSPALMTDPCMSLSPPCFT--EEDRFSLE
DGCELVPRHLRGRRATGSAATAASSPAAAAGDSPALMTDPCMSLSPPCFT--EEDRFSLE
DGCDLVPRHLRGRRASGSAGAAASPSAAAAGERQALLTDPCMSLSPPCFT--EEDRFSLE
----------------Q----AVSNEFS--SMGSGSADGACAADDFDCYSGSVQDRFGME
NG----------DR-------------------------VTRNVEVTAEEEKIRDKLGYE
. .
:::. *

66
70
70
136
145
45

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

AVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHS--TFHGEDKLISVEDLWKAW
ALQTIHKQMDDDKDGGIEVEESDEFIREDMKYKDATNKHS--HLHREDKHITIEDLWKRW
ALQTIHKQMDDDKDGGIEVEESDEFIREDMKYKDATNKHS--HLHREDKHITIEDLWKRW
ALQTIHKQMDDDKDGGIEVDESDEFIREDMKYKDATNKHS--HLHREDKHITVEDLWKQW
AIASLHRQLDDDDNGNIDLSESDDFLREELKYDSGYEKRQKAFHFNDDMHISVKELWEAW
AIRDIHRDMDDDHSGSIDRNESTGFMKEDMQMRGSERTRRENKFHGDDDAITVDDLWEAW
*: :*: :*** .*.:: .** *::*::: .
.:
. :* *::.:**: *

124
128
128
194
205
105

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

KSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDR
KTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDR
KTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDR
KTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHETSFMISQLKISDR
LRSEVHNWTIEQTTDWLAQSVQLPQYVDLFKLHKVTGAALPRLAVNNLQYVGNVLGIKDP
FESIERTWTNERLVEWLINDVNLPSIVEAVKAKKIDGKILPRFASPNSDFLNKELGIKSS
*
.** :
:**
*:**. . .: :: * :**:* :
. * :..

Human ST1
Human ST2
Human ST2b
Mouse ST2
Fly STIM
Worm STIM

SHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNR-YSKEHMKK
SHRQKLQLKALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAYTQNK-TSKEHVAK
SHRQKLQLKALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAYTQNK-TSKEHVAK
SHRQKLQLKALDVVLFGPLTRPPHNWMKDFILTISIVIGVGGCWFAYTQNK-TSKEHVAK
IHKQKISLKAMDVVLFGPPRETGTRW-KDYILVTLLLSAIIGCWYAYQQNK-NAKRHLRR
VYRQKLRLNSLDVVLFGYKDNN--NRTKDILLAFLAL-LLTSLIFLYVRQKQKAQQKVNE
::**: *:::*.****
. ** :*.
: : . : * ::: ::.:: .

Variable N-terminal Region

Canonical EF-hand

Noncanonical EF-hand

SAM

TM

184
188
188
254
265
165
243
247
247
313
323
222
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B.
Human ST2
Mouse ST2
Rat ST2
Turtle ST2
Zebrafish ST2

Cys15

Cys53

Cys60

MLVLGLLVAGAADGCELVPRHLRGRRATGSAATAASSPAAAAGDSPALMTDPCMSLSPPC
MLLFGLLVAGVADGCDLVPRHLRGRRASGSAGAAASPSAAAAGERQALLTDPCMSLSPPC
MLLFGLLVAGVADGCDLVPRHLRGRRASGSAGAAASPSAAAAGERQALLTDPCMSLSPPC
LLLLGLLLAAAAAGCELESGDVARGRRRGG---------ASAAESPAVMTDTCSSLSPPC
LVLRGLIICV----CSSDQA---------------QQQPGLNRDTTVTPIDTCLQMSPPC
::: **::.
*.
.
: .
* * .:****

60
126
60
75
50

Fig. 1.3. Primary sequence alignment of STIM proteins. A. Multiple sequence alignment of
luminal STIM protein regions. Primary sequences of STIM from human to lower-order organisms
are aligned, including: Homo sapiens STIM1 (Human ST1; NCBI accession NP_003147.2); Homo
sapiens STIM2 (Human ST2; NCBI accession NP_065911.3); Homo sapiens STIM2b (Human
ST2b; NCBI accession NP_001162589.1); Mus musculus STIM2 (Mouse ST2; NCBI accession
AAI45002.1); Drosophila melanogaster STIM (Fly STIM; NCBI accession NP_523357.2);
Caenorhabditis elegans STIM (Worm STIM; NCBI accession CCD73857.1). Conserved domains
are highlighted using various colours: Signal Peptide, purple; Variable N-terminal Region: red;
Canonical EF-hand, yellow; Non-canonical EF-hand, green; Sterile a motif, blue; Transmembrane
domain, orange. B. Multiple sequence alignment of the STIM2 variable N-terminal region from
human to the lowest order Stim2 containing organism (Cai, 2007), including Homo sapiens STIM2
(Human ST2; NCBI accession NP_065911.3); Mus musculus STIM2 (Mouse ST2; NCBI
accession AAI45002.1); Rattus norvegicus STIM2 (Rat ST2; NCBI accession NP_001099220);
Terrapene exicana triunguis STIM2 (Turtle ST2; NCBI accession XP_024060054.1); and Danio
rerio STIM2 (Zebrafish ST2; NCBI accession XP_002660454.3). Conserved Cys residues
between STIM2 homologs are highlighted in red; positions are relative to Homo sapiens STIM2.
Alignments were performed using Clustal Omega (EMBL-EBI) software. Fully conserved (*),
highly conserved (:), partially conserved (.).
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1.4.2 Orai organization
While the high-resolution structure of the full-length human Orai channel has not been elucidated,
a high-resolution crystal structure of the Drosophila melanogaster Orai channel exits. Both
tetrameric and hexameric models have been proposed for Orai assembly during CRAC channel
activation; however, recent evidence more strongly supports the hexameric conformation. First,
the D. melanogaster crystal structure unequivocally shows that a single Orai channel adopts a
hexameric quaternary structure (Hou et al., 2012). Moreover, HEK293 cells stably expressing
STIM1 transfected with concatenated Orai1 channel constructs (i.e. tetramers and hexamers)
revealed that Orai1 tetramers utilize only their N-terminal subunits in CRAC channel formation
compared to all subunits in Orai1 hexamers (Cai et al., 2016). Consequently, Orai subunits most
likely form a hexameric channel configuration when recruited by STIMs to mediate cytosolic Ca2+
flux.
Both crystal structure and bioinformatics analysis (i.e. sequence alignments) reveal that Orai is
composed of four TM helices (i.e. TM1-TM4) localized at the PM (Feske et al., 2006; Hou et al.,
2012). TM1 lines the pore and is responsible for the formation of the Ca2+ selectivity filter.
Specifically, residue Glu106 of human Orai1 is required for Ca2+ binding, resulting in the high
selectivity of CRAC channels. TM2 and TM3 are involved in promoting structural stability of the
TM1 helix, whereas TM4 interacts with a neighbouring TM4 helix of another Orai subunit to
stabilize dimer building blocks within the hexameric structure (Enomoto et al., 2017).
Both the N- and C-termini of Orai are located in the cytosol and facilitate the interaction with
STIMs. As mentioned above, a small subset of STIM2 is in an active conformation and coupled
to Orai1 channels under resting conditions (Brandman et al., 2007). For the majority of STIM1
and the remaining fraction of STIM2 molecules, upon ER Ca2+ store depletion, the EFSAM
domains undergo a destabilization-coupled oligomerization. This oligomerization rearranges the
TM domains and closely apposes the CC1 domains within STIM dimers. This CC1 clustering
results in a release of the CAD/SOAR domain, which interacts with CC1 under ER Ca2+ loaded
conditions. The release of the CAD/SOAR domain promotes further oligomerization of STIM
molecules, and translocation of STIMs to ER/PM junctions. At these junctions, the polybasic
domains interact with PM phosphoinositides and the C-terminal of Orai interacts with the
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CAD/SOAR domain of STIMs to form CRAC channels (Stathopulos et al., 2013). Gating of the
Orai1 channels requires interactions of CAD/SOAR with both the N- and C-termini of Orai,
although the C-terminal interactions are higher affinity. All three Orai homologs (i.e. Orai1, Orai2,
and Orai3) share conserved TM helices as well as residues required for Ca2+ sensitivity and
selectivity. Interestingly, all forms of human Orai protein can assemble into functional heteromeric
CRAC channels, each with unique functional characteristics based on STIM:Orai protein
combinations (Lis et al., 2007).

1.4.3 STIM and Orai function
Together STIM and Orai proteins mediate both SOCE and basal Ca2+ homeostasis. While both
STIMs can elicit SOCE, STIM1 is the principal regulator whereas STIM2 is primarily involved in
basal Ca2+ regulation.
SOCE is triggered by agonist-induced ER luminal Ca2+ depletion. Normally, Ca2+ is bound to the
EFSAM region of STIMs, maintaining an inactive, stable state. As reviewed above, following ER
Ca2+ depletion, Ca2+ dissociation from the EFSAM results in destabilization and oligomerization
of STIMs. These events lead to structural changes within the cytosolic CC domains such that
STIMs adopt an “extended” conformation, translocate to ER/PM junctions and together with
Orai1, form CRAC channels. This molecular collaboration ultimately causes the influx of
extracellular Ca2+ into the cytosol, otherwise known as SOCE. It should be noted that resting,
inactive STIM molecules are likely dimerized (Soboloff et al., 2012; Yang et al., 2012). Thus, the
initial structural changes that occur during activation take place within the dimer; however,
activated dimers further cluster during Orai1 activation. Interestingly, STIM1 and STIM2 can
undergo heterodimerization, during which different combinations of STIM dimers differentially
regulate SOCE (Fig. 1.4). Under high agonist stimulation, where ER Ca2+ levels drop below ~0.1
mM, STIM1 dimers predominately mediate larger influxes of Ca2+ into the cytosol through Orai1mediated CRAC channels. Conversely, under low agonist stimulation, where ER Ca2+ levels fall
between ~0.1-0.4 mM, STIM2 dimers predominately mediate smaller influxes of Ca2+ into the
cytosol through Orai1-mediated CRAC channels (Berna-Erro et al., 2009; Brandman et al., 2007;
Liou et al., 2005; Soboloff et al., 2006).
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CRAC channels can be deactivated by a process known as Ca2+-dependent inactivation (CDI). The
ID of STIM1 provides a negative feedback signal to Ca2+ entry by triggering the inactivation of
Orai1-mediated CRAC channel currents (Derler et al., 2009; Roos et al., 2005). Notably, a Ca2+
binding protein, calmodulin (CaM), is able to bind STIMs and Orai1 to facilitate Ca2+-CaMdependent CRAC channel inhibition. Isothermal titration shows that CaM binds to the polybasic
C-termini of STIMs in a Ca2+ dependent manner (i.e. Kd ~1 µM with Ca2+ and ~100 µM without
Ca2+), a region critical for STIMs translocation and trapping at the PM, thereby disrupting STIMOrai1 interactions and inactivating Orai1 channels (Bauer et al., 2008; Mullins et al., 2009; Yuan
et al., 2009). Moreover, crystallography and isothermal titrations reveal that both the N- and Cterminal lobes of CaM can bind to the N-terminus of Orai1 in a Ca2+ dependent manner via
hydrophobic interactions, thereby disrupting STIM-Orai1 interactions and inactivating Orai1
channels (Liu et al., 2012). Taken together, these data indicate that STIMs, together with Orai1,
are mediators of SOCE and CRAC channel activity.
In summary, STIM2 aptly acts as an effective basal Ca2+ homeostatic feedback regulator due to
several important differences compared to the STIM1 paralog. First, the EF-hand of STIM2 (Kd ~
0.4-0.8 mM) has a lower Ca2+ affinity compared to STIM1 (Kd ~ 0.2-0.6 mM) (Brandman et al.,
2007; Soboloff et al., 2012; Stathopulos et al., 2006). Consequentially, STIM2 is more sensitive
to smaller decreases in luminal Ca2+ levels from resting levels. Second, the C-terminal polybasic
domain of STIM2 has a stronger affinity for PM-bound PIP2 than that of STIM1, which can tether
STIM2 to the PM (Yuan et al., 2009). Third, compared to the SOAR domain of STIM1 (SOAR1),
the SOAR domain in STIM2 (SOAR2) further unfolds the cytosolic region of STIM2, placing the
Orai-activating SOAR2 region in the vicinity of Orai1 at rest (Zheng et al., 2018). Hence, SOAR2
has to move a shorter distance to activate Orai1 when compared to SOAR1. Fourth, when
expressed in cells, a higher fraction of STIM2 appears to be pre-clustered near ER/PM junctions
compared to STIM1, which causes constitutive activation of CRAC channels (Brandman et al.,
2007). As a result, STIM2 is partially activated at resting ER luminal Ca2+ concentrations (0.4 0.7 mM) and constitutively induces basal Ca2+ entry through STIM2-activated Orai1 channels to
regulate Ca2+ homeostasis (Fig. 1.4B). Collectively, these data indicate that, together with Orai1,
STIM2 also functions as an efficient basal Ca2+ homeostatic feedback regulator.
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1.5

STIM-associated pathologies

The physiological importance of STIM proteins are emphasized by studies probing STIMmediated Ca2+ flux in health and disease. STIM1/Orai1 double knockout mice typically die in
utero or shortly after birth due to respiratory and immunological pathologies (Cahalan and Chandy,
2009; Vig et al., 2008). Additionally, mice lacking STIM2 progressively die between ~4 – 8 weeks
after birth (Berna-Erro et al., 2009; Oh-Hora et al., 2008). Within the immune system, STIM1 is
essential for Fcg receptor activation on phagocytes, which can trigger autoantibody and immune
complex-induced diseases, such as systemic lupus erythematosus and rheumatoid arthritis (Braun
et al., 2009). Despite the essential role of STIM1, evidence suggests a cooperative function
between STIM homologs. While helper T-cell-specific deletion of STIM1 impairs T-cell function,
the resultant phenotype is incomplete, suggesting a compensatory role of STIM2 (Ma et al., 2010).
Moreover, B-cell specific deletion of STIM1 also results in an attenuated function wherein
interleukin-10 production is significantly diminished; when both STIMs are deleted, interleukin10 production is completely abolished (Matsumoto et al., 2011). Thus, STIM1 and STIM2 work
in concert to mediate cellular responses within the immune system. While the pathological
mechanism by which STIM proteins elicit disease are poorly understood, these results indicate that
STIMs are essential for sustaining life and abnormalities in structure and function can result in a
wide range of pathological complications (see below).

1.5.1 STIM1-associated pathologies
Perhaps the most widely studied system harbouring mutated STIM1 protein is the immune system.
Mutations to various regions in STIM1 ultimately disrupt Ca2+ homeostasis, which can give rise
to immunological pathologies. A single point mutation in the CC1 region of STIM1 (i.e.
Arg304Trp) results in the autosomal dominantly inherited Stormorken Syndrome due to
upregulated SOCE, which is characterized clinically by anemia, thrombocytopathy, and tubular
aggregate myopathy (Misceo et al., 2014). On the other hand, a missense mutation in the CC3
region of STIM1 (i.e. Arg429Cys) results in an autosomal recessively inherited severe combined
immunodeficiency-like syndrome due to reduced SOCE, which is characterized clinically by an
increased susceptibility to infections (Maus et al., 2015).
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1.5.2 STIM2-associated pathologies
While there are currently no identified pathologies caused by single mutations to human STIM2
alleles, upregulated and hyperactivated STIM2 has been linked to numerous pathological
conditions, especially within the nervous system. Compared to STIM1, STIM2 expression is
relatively higher in neurons, suggesting that STIM2 plays a more prominent role in these cells
(Lopez et al., 2012b). Specifically, STIM2 is involved in synaptic function and neuronal survival.
Recent evidence using a conditional knockout mouse model suggests that STIM2 is involved in
long-term potentiation of hippocampal neuronal synapses, and that deletion of STIM2 impairs
plasticity (Yap et al., 2017). Moreover, STIM2, but not STIM1, was shown to be downregulated
in mouse models of Alzheimer’s disease (AD), which results in disturbed Ca2+ homeostasis
concomitant with large losses of hippocampal neurons (Sun et al., 2014). Consistent with this
report, only STIM2 overexpression was shown to correct aberrant Ca2+ flux in a similar mouse
model of AD (Zhang et al., 2015). While not yet explored, STIM2 is likely involved in similar
neurodegenerative diseases characterized by perturbed Ca2+ homeostasis.

1.6

STIM post-translational modifications

Proteins that mediate cell signaling cascades are often able to adopt multiple structural
conformations which promote distinct functions. Post-translational modifications can play a
pivotal role in controlling both intra- and inter-molecular interactions associated with biological
function (Hunter, 1995). The CAD/SOAR domain of STIMs can undergo phosphorylation events
that impact both structure and function (Table 1.1). STIMs mediate both store-dependent CRAC
channel as well as store-independent arachidonic acid-regulated Ca2+-selective (ARC) channel
activations (Mignen et al., 2007; Shuttleworth, 2017). However, the underlying mechanism by
which STIMs differentially activate these two processes was unknown until the discovery that
phosphorylation of Thr389 by protein kinase A (PKA) induces structural changes leading to the
selective activation of ARC channels (Thompson and Shuttleworth, 2015). Using molecular
dynamics simulations and optical spectroscopy, it was demonstrated that phosphorylation of
Thr389 in STIM1 induces a helical extension of the C-terminal region of the CC2 domain, resulting
in an increased stability of the helix (Thompson et al., 2018). It is this structural conformation
mediated by Thr389 phosphorylation that establishes STIM1 specificity in activating ARC
channels over CRAC channels.
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Tyrosine phosphorylation of STIM1 has been identified and may be required for STIM1 to couple
to Orai1 in platelets (Lopez et al., 2012a). STIM1 phosphorylation has been detected at Tyr361 of
the CAD/SOAR region in endothelial cells (Table 1.1). This phosphorylation is mediated by
proline rich kinase 2 (Pyk2) following ER Ca2+ store depletion (Yazbeck et al., 2017).
Interestingly, when this phosphorylation site was conservatively mutated (i.e. Tyr361Phe), STIM1
was able to oligomerize, but unable to recruit Orai1 subunits, thus preventing activation of the
SOCE pathway (Yazbeck et al., 2017). It is noteworthy that Tyr361 forms self-stacking
interactions in the CAD/SOAR crystal and CC1-CC2 NMR dimer interfaces. Thus, Tyr361
phosphorylation may affect the dimer architecture of the critical CAD/SOAR region, and thereby
also affect interactions with Orai1.
Outside CAD/SOAR, STIM1 is phosphorylated by extracellular-signal-regulated kinase 1 and 2
(ERK1/2) at Ser575, Ser608 and Ser621, as observed in HEK293 cells (Pozo-Guisado et al., 2010)
(Table

1.1).

When

ERK1/2

phosphorylation

sites

were

mutated

in

STIM1

(i.e.

Ser575Ala/Ser608Ala/Ser621Ala), the apparent binding affinity of Orai1 was reduced, thereby
suppressing SOCE in HEK293 cells (Pozo-Guisado et al., 2010). Ser486 and Ser668 have also
been identified as mitosis-specific phosphorylation sites (Smyth et al., 2009) (Table 1.1). Mitotic
cells co-expressing Orai1 and fluorescently-tagged STIM1 Ser486Ala/Ser668Ala displayed higher
levels of SOCE when compared to the same mitotic cells expressing wildtype STIM1 (Smyth et
al., 2009). Thus, site-specific phosphorylation of STIM1 can either promote (Tyr361, (Ser575,
Ser608, Ser621) or inhibit SOCE (Thr389, Ser486, Ser668), adding yet another layer of regulation
to STIM1 function.
Cysteine S-glutathionylation is the covalent and reversible attachment of a tripeptide glutathione
moiety to a cysteine thiol. S-Glutathionylation is commonly promoted under oxidative stress and
is implicated in redox signaling (Dalle-Donne et al., 2009; Gallogly and Mieyal, 2007). In response
to oxidative stress, STIM1 undergoes S-glutathionylation near the conserved luminal Ca2+-sensing
domain (Table 1.1). Specifically, after subjecting DT40 cells to oxidative stress, STIM1 was found
to be S-glutathionylated at Cys56; moreover, the modification at this position constitutively
activated Ca2+ entry via CRAC channels, independent of ER luminal Ca2+ concentrations
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(Hawkins et al., 2010). While STIM1 is typically activated when intracellular ER Ca2+ levels are
depleted, S-glutathionylation of Cys56 decreases the affinity of the immediately downstream
canonical EF-hand for Ca2+, thereby leading to STIM1 activation and SOCE even under replete
ER luminal Ca2+ conditions (Hawkins et al., 2010).
N-linked glycosylation is the covalent attachment of an oligosaccharide to the amide nitrogen of
an asparagine residue via a series of enzymatic reactions in the ER and Golgi. N-glycosylation is
distinct from O-glycosylation which occurs on the side chain hydroxyl groups of Ser or Thr
residues (Moremen et al., 2012). A minor fraction of STIM1 is located on the PM with the EFSAM
domain directed into the extracellular space (Lopez et al., 2006; Manji et al., 2000; Spassova et
al., 2006b; Williams et al., 2001; Zhang et al., 2005b). This cell surface targeting is mediated by
N-glycosylation of Asn131 and Asn171 (Csutora et al., 2008; Czyz et al., 2009; Kilch et al., 2013;
Manji et al., 2000; Mignen et al., 2007; Williams et al., 2001). Both these Asn residues are located
within the EFSAM domain, and recent solution NMR approaches have shed light onto the
structural mechanisms of regulation via modifications at these sites (Choi et al., 2017a; Choi et al.,
2017c). Site-selective covalent attachment of glucose at Asn131 and Asn171 in isolated STIM1
EFSAM resulted in a reduced Ca2+ binding affinity, concomitant loss in stability and enhanced
oligomerization propensity of the domain; moreover, the two simultaneous modifications were
found to cause structural changes which pervaded through the EFSAM core (Choi et al., 2017a).
Consistent with these structural and biophysical alterations to EFSAM, blocking N-glycosylation
in full-length STIM1 via Asn131Gln/Asn171Gln results in diminished SOCE in HEK293 cells
(Choi et al., 2017a). Interestingly, STIM1 can also O-link N-acetylglucosamine, resulting in
suppressed SOCE (Zhu-Mauldin et al., 2012). The likely target of this modification is the STIM1
cytosolic domains given that O-glycosylation typically takes place in the cytosol or nucleus and
the cytosolic region of STIM contains a sequence rich in Pro, Glu, Ser, Thr (Rogers et al., 1986)
which has high O-linked modification propensity (Zhu-Mauldin et al., 2012).
S-Nitrosylation is the covalent addition of a NO moiety to a reduced cysteine residue. Typically,
S-nitrosylation occurs under nitrosative stress, which can profoundly modify protein function and
stability (Anand and Stamler, 2012; Benhar et al., 2006). STIMs are susceptible to S-nitrosylation
near the conserved, Ca2+ sensing luminal EFSAM domain. Recent evidence demonstrates that S-
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nitrosylation at Cys49 and Cys56 stabilizes the luminal domain of STIM1, thereby suppressing
Ca2+ sensitivity and inhibiting SOCE activation (Gui et al., 2018; Zhu et al., 2018) (Table 1.1).
While these results suggest that S-nitrosylation reduces SOCE, an in vivo model studying the
effects S-nitrosylation has on cardiac hypertrophy has not yet been studied. Moreover, STIM2 is
also a regulator of SOCE and plays a prominent role as a basal Ca2+ homeostatic feedback regulator
(Brandman et al., 2007). However, the effects of S-nitrosylation on STIM2 stability and the
resultant effects in either SOCE or basal Ca2+ regulation have not yet been investigated in any
capacity.

1.6.1 S-Nitrosylation mechanism
Protein S-nitrosylation is a chemical redox reaction whereby a NO moiety oxidizes a reduced
cysteine sulfhydryl group, yielding an S-nitrosothiol (S-NO) group (Fig. 1.5). Specifically, Snitrosothiol formation is thought to occur via a recombination between a thiyl radical and NO or
via oxidation of NO to N2O3 in the presence of an electron acceptor (Broniowska and Hogg, 2012).
NO is endogenously produced in humans from the breakdown of L-arginine via a group of
enzymes termed NO synthases (NOS), which are activated by myriad biological signals and
conditions. Three structurally and functionally distinct isoforms of NOS exist: neuronal NOS
(nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS). nNOS and eNOS are typically
expressed constitutively and have a Ca2+-dependent activity, while iNOS is only highly expressed
after pro-inflammatory cytokine production and has a Ca2+-insensitive activity. Collectively, these
three NOS isoforms are able to produce NO under distinct cellular environments to regulate
important pathophysiological functions, most notably within the cardiovascular system, wherein
the importance of tightly regulated NO levels become apparent. Typically, NO production by
iNOS is elevated in the myocardium of mammals after myocardial infarctions (Drexler et al., 1998;
Feng et al., 1999). Interestingly, mice deficient in iNOS [i.e. iNOS (-/-)] have significantly lower
mortality rates after myocardial infarctions induced by left coronary artery ligation when compared
to wildtype iNOS mice (Feng et al., 2001), suggesting that this increased NO production
contributes to myocardial dysfunction and mortality. Similarly, decreased NO production by eNOS
is detrimental to the nascent mammalian heart, since mice deficient in eNOS [i.e. eNOS (-/-)]
experience significantly increased postnatal mortality compared to wildtype eNOS mice due to
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atrial and ventricular septal defects, pulmonary congestion, and increased cardiomyocyte apoptosis
(Feng et al., 2002).
Endogenous S-nitrosoglutathione (GSNO) is comprised of a glutathione (GSH) tripeptide
covalently attached to a NO moiety, thereby serving as a biological reservoir of NO to regulate
cellular levels of this compound within the body. GSNO reductase (GSNOR), a ubiquitously
expressed enzyme, can catalyze the breakdown of GSNO using an electron donor (i.e. NADPH),
to produce oxidized glutathione (i.e. GSSG) and an intermediate (i.e. GSNHOH), thereby lowering
GSNO levels (Barnett and Buxton, 2017). Thus, cells have the protein machinery to produce NO,
to store NO in the form of GSNO, and to tightly regulate cellular NO levels in order to control the
level of protein S-nitrosylation in cells.

1.6.2 Effects of S-Nitrosylation
S-Nitrosylation plays an important role in the regulation of protein function. Interestingly, Snitrosylation can mediate competing functions in a protein, depending on the specific Cys residue
modified. After treatment with a specific agonist, S-nitrosylation of Ca2+/CaM-dependent protein
kinase II at Cys290 causes autonomous kinase activation, while S-nitrosylation at Cys273 reduces
kinase activity (Erickson et al., 2015).
Hyperactive CRAC channels in mammalian cardiomyocytes can lead to pathological hypertrophy
mediated by the transcription factor NFAT; however, recent evidence suggests that S-nitrosylation
of STIM1 at Cys49 and Cys56 mediated by nNOS inhibits STIM1-mediated ICRAC in mammalian
cardiomyocytes (Gui et al., 2018). Interestingly, adenoviral nNOS infection inhibits phenylephrine
induced hypertrophy in cardiomyocytes (unpublished data; Feng laboratory). While Snitrosylation of human STIM1 at Cys49 and Cys56 were shown to suppress function and attenuate
pathological cardiomyocyte hypertrophy, the effects of human STIM2 S-nitrosylation at the
conserved Cys53 and Cys60, as well as the unique Cys15 in health and disease remains unknown.
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Table 1.1 Summary of detected post-translation modifications on STIM1.
Modification

a
b

Location on STIM1a Cellular localization Effect on SOCE

References

S-glutathionylation

Cys56 – N-terminal
variable

ER lumen

enhances

(Hawkins et al., 2010)

N-glycosylation

Asn131 – SAM
domain

ER lumen and
extracellular space

enhances

(Choi et al., 2017a;
Csutora et al., 2008; Czyz
et al., 2009; Kilch et al.,
2013; Manji et al., 2000;
Mignen et al., 2007;
Williams et al., 2001)

N-glycosylation

Asn171 – SAM
domain

ER lumen and
extracellular space

enhances

(Choi et al., 2017a;
Csutora et al., 2008; Czyz
et al., 2009; Kilch et al.,
2013; Manji et al., 2000;
Mignen et al., 2007;
Williams et al., 2001)

O-glycosylation

Ser/Thr – P/S

cytosol

suppresses

(Zhu-Mauldin et al.,
2012)

phosphorylation

Tyr361 – SOAR/CAD

cytosol

enhances

(Lopez et al., 2012a;
Yazbeck et al., 2017)

phosphorylation

Thr389 – SOAR/CAD

cytosol

suppresses

(Thompson and
Shuttleworth, 2015;
Thompson et al., 2018)

phosphorylation

Ser486 – OASF,
Ser668 – P/S

cytosol

suppresses

(Smyth et al., 2009)

phosphorylation

Ser575, Ser608,
Ser621 – P/S

cytosol

enhances

(Pozo-Guisado et al.,
2010)

S-nitrosylationb

Cys49, Cys56 –
N-terminal variable

ER lumen

suppresses

(Zhu et al., 2018)

See Fig. 1.2 for relative location in sequence space and on STIM1 domain architecture.
Information not included in original publication.
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1.7

Rationale

The STIM2 gene first appeared in the Euteleostomi lineage (i.e. bony vertebrae), most likely due
to a duplication of an ancestral STIM gene (Cai, 2007; Williams et al., 2001). Despite the high
sequence similarity between STIM homologs, many differences exist, underlying the unique
molecular and functional properties of STIM2. Recently, two Cys residues within the N-terminal
domain of STIM1 (i.e. Cys49 and Cys56) were shown to be important functional regulatory sites
through post-translational modifications. Specifically, S-nitrosylation of these residues suppresses
Ca2+ sensitivity and inhibits SOCE (Zhu et al., 2018), whereas S-glutathionylation of Cys56
constitutively activates STIM1 mediated SOCE (Choi et al., 2017b). While these two Cys residues
are conserved between STIM vertebrate homologs (i.e. STIM2 Cys53 and Cys60), STIM2 contains
an additional and non-conserved Cys within its N-terminal domain (i.e. Cys15). Interestingly, this
unique Cys is present in the earliest known STIM2-containing organism (i.e. Danio rerio; zebra
fish) (Fig. 1.3B), highlighting the evolutionary importance of this residue. As a result, the Cys15
residue may serve as an additional post-translational modification site whereby S-nitrosylation
affects the structure and function of STIM2, underlying its unique function as a basal Ca2+
homeostatic feedback regulator.
I posit that the stability and function of STIM2 are also regulated by luminal domain Snitrosylation at Cys15, Cys53, and Cys60, and that S-nitrosylation of the unique Cys15 residue
contributes to distinct functions between the STIM homologs. Thus, the aim of my study is to
characterize the biophysical, structural and functional effects of STIM2 luminal domain Snitrosylation to enhance our understanding of basal Ca2+ regulation and the role of STIM2 in health
and disease.

1.8

Hypothesis and objectives

Hypothesis:
I hypothesize that S-nitrosylation of STIM2 near the luminal Ca2+ sensing domain affects its
biophysical properties including structure, stability, oligomerization and activation. Thus, I posit
that S-nitrosylation of STIM2 affects SOCE and basal Ca2+ homeostasis in mammalian cells.
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Aim 1: To determine the effect of S-nitrosylation on the biophysical and structural properties of
the full luminal domain and variable N-terminal region of human STIM2.
The luminal domain of H. sapiens STIM2 (NCBI GeneID 57620) (i.e. residues 15-217), comprised
of the Ca2+-sensing EFSAM domain as well as the far N-terminal region containing the three
cysteine residues available for S-nitrosylation, was cloned into a pET-28a vector. STIM2 has
3×cysteine residues (i.e. Cys15, Cys53 and Cys60) compared to the 2×cysteine residues in the
luminal domain of STIM1 (i.e. Cys49 and Cys56), and thus has an additional potential Snitrosylation site that may contribute to the differential regulation of Ca2+ flux by STIM2. As such,
site-directed mutagenesis was applied to generate single, double and triple Cys to Ser STIM2
luminal domain mutants. Wildtype and mutant constructs were expressed in E. coli and purified
using metal-affinity and size exclusion chromatography. Moreover, the variable N-terminal region
of H. sapiens STIM2 (NCBI GeneID 57620) (i.e. residues 15-66) containing the three modifiable
Cys residues was cloned into a pGEX-4T1 vector, expressed in E. coli and purified using affinity
and size exclusion chromatography. Purified STIM2 luminal domain (i.e. residues 15-217) and
variable N-terminal region (i.e. residues 15-66) proteins were exchanged in a buffer with the excess
NO donor GSNO to study the effects of S-nitrosylation compared to the native protein exchanged
into dithiolthreitol (DTT) buffer. A wide range of spectroscopic techniques were applied to
characterize the biophysical and structural properties of these proteins under reducing and Snitrosylating conditions.
Aim 2: To elucidate the effect of S-nitrosylation on the functional properties of full-length STIM2
in mammalian cells.
The full-length sequence of wildtype H. sapiens STIM2 (NCBI GeneID 57620) was cloned into a
pCMV6 mammalian expression vector with a constitutive promoter. Site-directed mutagenesis
was used to generate Cys15Ser single-mutant and Cys15Ser/Cys53Ser/Cys60Ser triple-mutant
constructs. HEK293T cells were co-transfected with Orai1 and different combinations of wildtype
and mutated STIM2 constructs, and fura-2-AM ratiometric fluorimetry was used to probe basal
Ca2+ and SOCE. Overnight GSNO incubation was used to study the effect of S-nitrosylation on
STIM2 function in the full-length molecular context.
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Chapter 2: Methods
2.1 Generation of recombinant vectors encoding human STIM2
In order to assess the biophysical properties associated with STIM2 variable N-terminal region Snitrosylation, the full luminal region (i.e. residues 15-217) of Homo sapiens STIM2 (NCBI
accession NP_065911.3) containing the region with three modifiable Cys residues available for Snitrosylation (i.e. Cys15, Cys53 and Cys60) together with the Ca2+-sensing EFSAM domain (i.e.
residues 67-204), was cloned into a pET-28a vector. Additionally, a pCMV6 vector encoding full
length H. Sapiens STIM2 (i.e. residues 1-746) fused to monomeric cherry fluorescent protein
(mCh) (i.e. pCMV6-mCh-STIM2) (Chung et al., 2018; Stathopulos et al., 2009; Zheng et al.,
2011a) was used in the present study to determine the functional properties associated with this
site-specific post-translational modification in vitro.
Furthermore, to uncover the importance that each S-nitrosylated Cys has on the biophysical and
functional properties of STIM2, polymerase chain reaction (PCR)-mediated -site directed
mutagenesis using either the pET-28a or pCMV6-mCh wildtype STIM2 vectors and mutagenic
primers (detailed in Table 2.1) were used to mutate various combinations of Cys residues to Ser
(Table 2.2). For the mutagenesis, either ~250 ng of the forward or reverse primers (Table 2.1) were
added to a 20 µL dH2O solution containing 1´ of the 5´ High Fidelity (HF) buffer (Thermo Fischer
Scientific), 2% (v/v) DMSO, ~100 ng of the vector template, 10 mM dNTPs, and 1 µL (0.02
units/µL) Phusion DNA polymerase (Thermo Fischer Scientific). The two solutions were first
subjected to 10 PCR amplification cycles in a LifeECO Thermocycler (BioER) using parameters
listed in Table 2.3. Upon completion, the resultant amplicons from both solutions were combined,
and the final mixture was subjected to another 25 amplification cycles using the parameters listed
in Table 2.3. The final amplicon products, as well as equal amounts of control template DNA and
a GeneRuler 1kb Plus DNA ladder (ThermoFisher), were separated on a 1.5% (w/v) agarose gel
prepared in 0.5× TRIS, acetic acid, ethylene diamine tetra acetic acid (TAE) running buffer
electrophoresed at 125 V for 60 minutes. Following electrophoresis, the gel was submerged in 0.5
µg mL-1 ethidium bromide (EB) solution and placed on a platform shaker for 30 min. The gel was
subsequently visualized under UV light at 302 nm. Amplification success was determined by a
higher relative intensity of the PCR product compared to control, template DNA. 15 units of Dpn1
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(New England BioLabs) was added to the remaining PCR product (~25 µL) and incubated for 3
hours at 37 °C in an incubator to digest the original methylated template DNA. To transform the
mutagenized vector into bacteria, 15 µL of the PCR product was incubated with 100 µL competent
DH5a E. coli, incubated on ice for 1 hour and subsequently heat shocked at 42 °C for 45 seconds.
The heat shocked cells together with the amplified digestion product were subsequently transferred
into 900 µL of Luria-Bertani (LB) broth media and incubated for 1.5 hours at 37 °C with constant
shaking at 190 revolutions per minute (rpm). After this time, the cells were pelleted by
centrifugation at 7,500 ×g for 5 min and resuspended in ~100 µL of LB. These resuspended cells
were plated on an agar plate containing 60 µg/mL kanamycin, and incubated overnight in an air
incubator at 37 °C. The next day, colonies were selected and grown overnight in 5 mL LB liquid
culture at 37 °C and 190 rpm. Finally, the mutant plasmids were isolated the next day using the
Presto Mini Plasmid Kit (GeneAid) according to the manufacturer’s protocol. Isolated plasmids
were subsequently sequenced at the Robarts DNA Sequencing facility (London, ON, CAN) using
the T7 reverse terminator primer to confirm the mutagenesis at the nucleotide level.
Finally, to study the structure of the variable N-terminal region of STIM2 (i.e. residues 15-66), the
DNA encoding this region was subcloned from a pET-28a-STIM2 vector containing the full
luminal domain (i.e. residues 15-217) into a pGEX-4T1 (GE Heathlcare) recombinant vector using
BamHI and EcoRI restriction sites. In order to obtain the STIM2 15-66 insert, a 150 µL PCR
mixture in dH2O was prepared, which contained 1´ of the 5´ HF buffer (Thermo Fischer
Scientific), ~30 ng of pET-28a-STIM2 15-217 template, ~500 ng each of the forward and reverse
primer (Table 2.1), 10 mM dNTPs, and 1µL (0.02 units/µL) Phusion DNA polymerase (Thermo
Fischer Scientific). The forward and reverse primers had BamHI and EcoRI restriction sites
incorporated at the 5’ and 3’ ends, respectively. The 150 µL PCR mixture was divided in equal
volumes and amplified for 35 cycles using a thermal cycler (Eppendorf Mastercycler) as described
in Table 2.3. The final PCR products were electrophoresed on a 1.5% (w/v) agarose gel as
described above for the mutagenesis. The agarose gel was visualized under UV light at 302 nm
and the amplicon band size (~159 base pairs) was assessed by comparing the fragment size to a
Gene Ruler 1kb Plus DNA ladder (Thermo Fischer Scientific). The corresponding fragment was
excised from the gel, transferred into a separate Eppendorf tube, and the DNA was subsequently
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isolated from the agarose gel using the GeneFlow Gel/PCR purification kit according to the
manufacture’s protocol.
Compatible sticky end overhangs were generated by double digestions of the isolated STIM2 1566 insert and target pGEX-4TI wildtype STIM2 15-217 vector using BamHI and EcoRI restriction
enzymes. The first digestion mixture was prepared using ~500 ng of the STIM2 15-66 insert, 4 µL
Cut Smart Buffer, and 0.5 µL of each restriction enzyme, while the second digestion mixture was
prepared using ~1 µg pGEX-4TI vector, 2 µL Cut Smart Buffer, and 1 µL of each restriction
enzyme in 8.5 µL dH2O. Each digestion mixture was incubated at 37 °C overnight in an incubator.
The following day, both digested samples were separated on an agarose gel, stained with ethidium
bromide, and visualized under UV light as described above. The digested DNA bands from both
the STIM2 15-66 insert and the pGEX-4TI vector with compatible sticky ends were excised from
the agarose gel using the GeneFlow Gel/PCR purification kit according to the manufacture’s
protocol.
In order to ligate the digested STIM2 15-66 insert into the pGEX-4T1 recombinant vector, 4.5 µL
dH2O, 3.0 µL of the digested pGEX-4TI vector, 10 µL of the digested STIM2 15-66 insert and 2
µL of 2´ T4 DNA ligation buffer (New England Biolabs) were combined into an Eppendorf tube.
The mixture was subsequently heated at 42 °C for 2 minutes, chilled on ice for 1 minute, and
supplemented with 1 µL T4 DNA ligase (New England Biolabs). The ligation reaction was carried
out by placing the mixture in a water bath at 16 °C for ~16 hours. The ligation product was
transformed into DH5a E. coli using a similar transformation approach described above for the
mutagenesis protocol, and the cells that successfully took up the plasmid were selectively grown
on agar plates containing 100 µg/mL ampicillin antibiotic.
The resultant transformed colonies were screened for the STIM2 15-66 insertion in the pGEX-4TI
recombinant vector by suspending individual colonies in 20 µL dH2O. Afterwards, 5 µL of this
solution was added to a 20 µL dH2O mixture containing 10 µL 2´ Taq Frogga Master Mix
(Froggabio) and ~250 ng each of pGEX forward and reverse primers. The entire mixture was
amplified in a thermocycler for 25 cycles using the parameters detailed in Table 2.3. The final
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PCR product was electrophoresed on an agarose gel, stained with ethidium bromide and visualized
under UV light as described above. Positive colonies that indicated the expected band size (~5000
bp) using the PCR screening approach were then grown in a 5 mL LB broth solution containing
100 µg/mL ampicillin overnight at 37°C in an incubator shaking at 200 rpm. The next day, pGEX4TI plasmids containing the STIM2 15-66 insert were isolated from the liquid cultures using the
Presto Mini Plasmid kit (Geneaid) as per the manufacturer’s protocol. DNA sequencing (Robarts
DNA Sequencing Facility, London, ON) using the pGEX forward primer confirmed that the
STIM2 15-66 insertion was in the correct reading frame in the pGEX-4T1 recombinant vector.
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Table 2.1. Oligonucleotide primers (Sigma-Aldrich, St. Louis, MO) used in this study.
Primer

Sequence

pET-28a
STIM2 15-217
Cys15Ser a
pCMV6-mCh
STIM2 1-746
Cys15Ser b
pET-28a
STIM2 15-217
Cys53Ser a
pET-28a
STIM2 15-217
Cys60Ser a
mCherry c

5’-GGCAGCCATATGGCTAGCAGCGAGCTTGTGCCCCGGCAC-3’

T7 Terminator

5’-GTGCCGGGGCACAAGCTCGCTGCTAGCCATATGGCTGCC-3’
5’-GAGCTGTACAAGGGTACCAGCGAGCTTGTGCCCCGGCAC-3’
5’-GTGCCGGGGCACAAGCTCGCTGGTACCCTTGTACAGCTC-3’
5’-CTCATGACAGATCCCAGCATGTCACTGAGTCCA-3’
5’-TGGACTCAGTGACATGCTGGGATCTGTCATGAG-3’
5’-TCACTGAGTCCACCAAGCTTTACAGAAGAAGAC-3’
3’-GTCTTCTTCTGTAAAGCTTGGTGGACTCAGTGA-5
c

pGEX-4T1
STIM2 15-66
Insertion d
pGEX Forward c,e
pGEX Reverse e

5’-GTTGGACATCACCTCCCACAACG-3’
5’-GCTAGTTATTGCTCAGCGG-3’
5’ GCCATATGGGATCCTGCGAGCTTGTGCCCCGGCACCTCCG-3’
5’-AATCTGTCGAATCCCTAAAAGCATGGTGGACTCAGTGACATGC-3’
5’- GGGCTGGCAAGCCACGTTTGGTG-3’
3’- CCGGGAGCTGCATGTGTCAGAGG-5’

a

Mutagenesis primer for wildtype pET-28a STIM2 15-217
Mutagenesis primer for wildtype pCMV6 STIM2 1-746
c
Sequencing primer
d
Subcloning primer for STIM2 15-66
e
Screening primer for pGEX-4T1 STIM2 15-66
b
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Table 2.2. Cys to Ser mutation strategy used in this study.
Vector:

Construct:
DNA used for SDM-PCR Construct generation:
Template:
Mutagenic Primers (Table 2.1)

pET-28aa

pCMV6b

a
b

STIM2 15-217
Wildtype

---

---

STIM2 15-217
Cys15Ser

STIM2
Wildtype

pET-28a STIM2 15-217
Cys15Ser Primers

STIM2 15-217
Cys53Ser

STIM2
Wildtype

pET-28a STIM2 15-217
Cys53Ser Primers

STIM2 15-217
Cys60Ser

STIM2
Wildtype

pET-28a STIM2 15-217
Cys60Ser Primers

STIM2 15-217
Cys53/60Ser

STIM2
Cys53Ser

pET-28a STIM2 15-217
Cys60Ser Primers

STIM2 15-217
Cys15/53/60Ser

STIM2
Cys53/60Ser

pET-28a STIM2 15-217
Cys15Ser Primers

STIM2 1-746
Wildtype

---

---

STIM2 1-746
Cys15Ser

STIM2 1-746
Wildtype

pCMV6-mCh-STIM2 1-746
Cys15Ser Primers

STIM2 1-746
Cys15/53/60Ser

STIM2 1-746
Cys15Ser

pCMV6-mCh-STIM2 1-746
Cys53Ser & Cys60Ser
Primers

Primers acquired from GeneScript
Primers acquired from Sigma Aldrich
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Table 2.3. PCR amplification parameters used in LifeECO (BioER) thermocycler
pET-28a
STIM2 15217
mutagenesis
10 Cycles +
25 Cycles

pCMV6
STIM2 1-746
mutagenesis

pGEX-4T1
STIM2 15-66
subcloning

pGEX-4T1
STIM2 15-66
Screening

10 Cycles +
25 Cycles

35 Cycles

35 Cycles

Temp
(°C)

Time
(sec)

Temp
(°C)

Time
(sec)

Temp
(°C)

Time
(sec)

Temp
(°C)

Time
(sec)

98

35

98

35

98

30

98

30

98

10

98

10

98

10

98

10

Annealing

54-55

30

53-55

30

54

30

54

30

Extension

72

180

72

180

72

30

72

30
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2.2 Protein expression and purification
2.2.1 Expression and purification of wildtype and mutant STIM2 15-217
The pET-28a vector harboring the wildtype STIM2 luminal domain corresponding to residues 15217, hereafter named STIM2 15-217, was transformed into BL21(DE3) E. coli using a similar
transformation approached described in section 2.1, and cells that successfully took up the plasmid
were selectively grown on agar plates containing 60 µg/mL kanamycin overnight at 37 °C. The
next day, one isolated individual colony was lifted from the kanamycin agar plate, inoculated into
a 65 mL LB mixture containing 60 µg/mL kanamycin and grown overnight at 200 rpm and 37 °C.
The following day, 10 mL of the LB culture was added individually to 6´ 4L sterile flasks
containing 1L of LB media and 60 µg/mL kanamycin. The 6´ 4L flasks each containing the liquid
culture and kanamycin antibiotics were subsequently grown in a New Brunswick ™ Excella ®
E25/E25R incubator shaker at 37 °C and 200 rpm until the optical density (OD) at 600 nm reached
a range of ~0.6-0.8. Once within the optimal OD range, each of the 6 flasks was supplemented
with a final concertation of 300 µM of isopropyl b-D-1-thiogalactopyranoside (IPTG) to induce
protein expression from the recombinant pET-28a vector, as IPTG is a lactose analog which binds
to a lac repressor also encoded within the vector. To minimize protein degradation and increase
protein expression, the temperature was dropped to 25 °C and incubated overnight at 190 rpm,
respectively. The following morning, the J2-21M Induction drive centrifuge equipped with a JA10
rotor (Beckman) was used to collect the BL21 cells via a centrifugation at 10,000 ´g at 4 °C for
40 minutes. Immediately after the centrifugation, the cell pellets were collected, pooled together
(~15 mL total wet cells) and stored at -80 °C until needed for protein purification.
To purify the STIM2 15-217 protein, the ~5 mL bacterial cell pellets were thawed and resuspended
in ~40 mL of 6 M guanidine hydrochloride, 20 mM Tris-HCl (pH=8) and 5 mM b-mercaptoethanol
(BME). The mixture was physically homogenized with using a 10-mL transfer pipette. To ensure
proper release of the protein from inclusion bodies, the homogenized mixture was rotated in a
hybridization oven at room temperature for 90 minutes. Moreover, in order to separate the
insoluble cell debris from the soluble protein supernatant, the homogenized mixture was
centrifuged using a JA20 rotor in a J2-21M Induction drive centrifuge at 12,000 ´g and 8°C for
40 minutes. The clarified lysate corresponding to the supernatant was collected immediately after
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the centrifugation, and subsequently rotated in a hybridization oven for 90 minutes after
supplementing with 500 µL of 50% (v/v) nickel-nitrilotriacetic acid (Ni2+-NTA) agarose HisPur
bead slurry (ThermoFischer Scientific) solution. Gravity filtration using a gravity flow protein
purification column (Bioscience) was used to retain the Ni2+-NTA beads bound to the N-terminally
fused hexahistidine (6´ His)-tag of the STIM2 15-217 protein. The protein bound beads retained
in the gravity column were washed 3´ with a 10 mL solution of 6 M Urea, 20 mM Tris-HCl
(pH=8), and 5 mM BME, and eluted 7´ in 2 mL aliquots with the same mixture supplemented
with 300 mM imidazole, a binding competitor of the 6×His-STIM2 15-217 for the Ni2+-NTA
beads. In order to ensure maximal displacement of the 6´His-tagged STIM2 15-217 protein from
the Ni2+-NTA beads, each 2 mL aliquot was incubated in the gravity column for 2 minutes before
flow through and collection. Separating the aliquots of each elution on a 15% (w/v) SDS-PAGE
gel followed by Coomassie Brilliant Blue (Thermo Fischer Scientific) staining confirmed the
presence of the protein (Fig 2.1A).
Elution fractions containing the protein of interest were pooled together into a 3.5 kDa molecular
weight dialysis membrane (BioDesign) and submerged into a 1 L protein refolding buffer
containing 20 mM TRIS-HCl (pH=8), 300 mM NaCl, 1 mM dithiothreitol (DTT) and 5 mM CaCl2.
In order to ensure homogeneous exchange between the buffers, a magnetic stir bar was used to
rotate the submerged dialysis membrane for ~18 hours at 4 °C. Following the protein refolding,
~1 unit of bovine thrombin (BioPharm Laboratories, Inc.) was added per ~ 1 mg of STIM2 15-217
directly into the dialysis membrane and gently stirred overnight at 4 °C in the protein refolding
buffer to cleave the N-terminally attached 6×His-tag. The completeness of thrombin cleavage was
determined by comparing the migration of pre- and post-thrombin protein samples separated on a
15% (w/v) SDS-PAGE gel followed by Coomassie blue staining for visualization (Fig. 2.1B).
After confirmation of the His-tag cleavage, 100 µM of 4-(2aminoethyl) benzenesulfonyl fluoride
(AEBSF) was added to protein solution to stop the thrombin enzyme activity.
Size-exclusion chromatography (SEC) using a HiLoad Superdex S200 20/60 PG column
connected to an AKTA Pure system (GE Healthcare) was used to achieve a STIM2 15-217 protein
purity >95% by separating impurities/contaminants by molecular weight. Prior to injecting the
refolded STIM2 15-217 protein, the column was washed with water, and subsequently equilibrated
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with a filter sterilized running buffer composed of 5 mM CaCl2, 20 mM TRIS-HCl (pH=8), 1 mM
DTT, and 150 mM NaCl. The protein elution was monitored by UV absorbance at 280 nm (UV
280) and collected in1 mL fractions on a 96´ deep well plate (Fig. 2.2A). The fractions that showed
a high UV 280 absorbance were separated on a 15% (w/v) SDS-PAGE gel and stained with
Coomassie blue to confirm the presence and purity of STIM2 15-217 (Fig. 2.2B). Elutions that
showed a single band at the theoretical molecular weight of the STIM2 15-217 protein (~22.4 kDa)
were pooled together, flash frozen using liquid nitrogen, and stored at -80 °C until use.
STIM2 15-217 single mutants Cys15Ser, Cys53Ser, Cys60Ser, double mutant STIM2 15-217
Cys53Ser/Cys60Ser, and triple mutant Cys15Ser/Cys53Ser/Cys60Ser proteins were expressed and
purified as described above for STIM2 15-217 wildtype protein. Protein concentrations were
estimated using UV extinction coefficients at 280 nm (e280 nm). The extinction coefficients were
e280 nm = 1.2944 mg/mL for wildtype STIM2 15-217, e280 nm = 1.2953 mg/mL for Cys15Ser,
Cys53Ser or Cys60Ser single mutant STIM2 15-217, e280

nm

= 1.2961 mg/mL for

Cys53Ser/Cys60Ser double mutant STIM2 15-217, and e280

nm

= 1.2970 mg/mL for

Cys15Ser/Cys53Ser/Cys60Ser triple mutant STIM2 15-217 proteins.
For the preparation of protein for use in solution nuclear magnetic resonance (NMR) spectroscopy
experiments, the wildtype STIM2 15-217 protein was uniformly 15N-labelled by expression in 1 L
minimal M9 media containing 42 mM Na2HPO4, 22 mM KH2PO4, and 8.6 mM NaCl supplemented
with 0.2% (w/v) D-glucose, 100 µM CaCl2 50 µM thiamine, 1 mM MgSO4, 1 µg/mL biotin and 1
mg/mL 15N-NH4Cl as the sole nitrogen source. The M9 salts were sterilized by autoclaving, while
the supplement mixture was filter sterilized into the 1 L of M9 salts using one 0.2 µm syringe filter
(Millipore). Prior to using the supplemented M9 media, one STIM2 15-217 BL21(DE3) E. coli
transformant was inoculated in 30 mL LB media and grown overnight for ~18 hours at 37 °C and
190 rpm. The bacterial cell pellet from this 30 mL starter culture was isolated via centrifugation
3,500 ´g for 30 minutes at 20 °C. The LB medium was decanted and the bacterial cells were resuspended in 10 mL of M9 media and subsequently transferred into the M9 media containing the
previously mentioned supplements. The remaining expression and purification steps of the 15Nlabelled protein were conducted exactly as described for the unlabelled protein.
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2.2.2 Expression and purification of wildtype STIM2 15-66
The pGEX-4TI vector harboring the wildtype STIM2 variable region corresponding to residues
15-66, hereafter named STIM2 15-66, was transformed into BL21(DE3) E. coli cells described for
the pET-28a STIM2 15-217 recombinant vector, with the exception that 100 µg/mL ampicillin
was used as the selection pressure. One colony was picked, inoculated into 30 mL LB media
containing 100 µg/mL ampicillin and grown overnight at 37 °C and 190 rpm constant shaking.
The following day, 10 mL of the bacterial culture was added to 1 L of LB supplemented with 100
µg/mL ampicillin, and grown at 37 °C and 190 rpm until the OD at 600 nm reached ~0.6-0.8.
Subsequently, a final concentration of 300 µM of IPTG was added to the culture to induce
recombinant protein expression under control of the lac operon, and the temperature was dropped
to 30 °C. The cells were grown for an additional 4 hours with 190 rpm constant shaking under
these conditions and subsequently collected into cell pellets by centrifugation as described
previously in section 2.2.1.
Since the pGEX-4TI vector expresses recombinant proteins as fusions with glutathione-Stransferase, the wet bacterial cell pellets were purified using GST Sepharaose beads (Genescript)
as described in the manufacturer’s protocol. In brief, ~5 mL cell pellets were suspended in a 45
mL wash buffer containing 1´ phosphate buffer saline (PBS) and 1 mM DTT. To ensure the
complete homogenization of cells, the cell mixture was sonicated on ice at 40 % power using the
Fischer Sonic Dismembrator Model 150 (Thermo Fischer Scientific) for 10 minutes in 3 second
on/off cycles. After sonication, 0.2 % (v/v) triton X-100 was added to the sonicated mixture. The
resultant homogenized mixture was rotated for 90 minutes at 4 °C in order to maximize release of
the GST-STIM2 15-66 fusion into solution. A JA20 rotor in a J2-21M Induction drive centrifuge
was used to separate the insoluble cell debris from the soluble GST-STIM2 15-166 by
centrifugation at 12,000 ´g and 8 °C for 40 minutes. The supernatant was immediately collected
and supplemented with a 1 mL solution of 50% (v/v) GST beads pre-equilibrated with 1´ PBS and
1 mM DTT. The resultant solution was rotated for another 90 minutes at 4 °C in order to promote
maximal binding of the GST beads to the GST-STIM2 15-66 fusion. Gravity filtration using a
gravity flow protein purification column (Bioscience) was used to retain the GST beads bound to
GST-STIM2 15-66 peptide. The collected beads were subsequently washed with 3´ 10 mL wash
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buffer containing 1´ PBS and 1 mM DTT. After washing, 15 mL of 20 mM TRIS-HCl (pH=7.5),
150 mM NaCl, 1 mM DTT and ~5 units of thrombin per ~1 mg of GST-STIM2 15-66 was added
to the closed gravity column. The closed column containing the GST beads and captured GSTSTIM2 15-66 was rocked overnight for ~18 hours at 4 °C in order to promote thrombin cleavage
and release of the STIM2 15-66 peptide. After rocking in this cold environment, the STIM2 15-66
peptide was eluted from the column, leaving behind the GST bound to the beads. Subsequent
washes of the GST beads with 3´ 1 mL wash buffer was used to collect residual peptide. Pre- and
post-thrombin solutions were separated on a 15% (w/v) SDS-PAGE gel and visualized by silver
staining to confirm the presence of the peptide. The samples containing the STIM2 15-66 peptide
were pooled together and further purified using SEC as described in 2.2.1, this time by monitoring
UV absorbance at 215 nm (UV215) and using a running buffer of 50 mM Na2HPO4 and 1 mM
DTT (Fig. 2.3A). The fractions that showed a high UV215 absorbance were separated on a 15%
(w/v) SDS-PAGE gel, silver stained (according to manufacturer’s protocol; Thermo Fisher
Scientific), and visualized to confirm for the purity of STIM2 15-66 peptide (Fig. 2.3B). Elutions
that showed a band migrating at the theoretical molecular weight of the STIM2 15-66 peptide (~3.2
kDa) were pooled together, flash frozen using liquid nitrogen, and stored at -80 °C until use in
experiments.
For protein concentration estimates of STIM2 15-66, a bicinchoninic acid assay (BCA) kit was
used according to the manufacturer’s protocol. Bovine serum albumin (Thermo Fisher Scientific)
was used to generate a standard curve for the protein concentration estimate.
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2.3 S-Nitrosylation of STIM2 recombinant proteins
All proteins of interest (i.e. wildtype STIM2 15-217, Cys15Ser, Cys53Ser, and Cys60Ser single
mutants, Cys53Ser/Cys60Ser double mutant, and Cys15Ser/Cys53Ser/Cys60Ser triple mutant)
were exchanged into the various buffers described in subsequent sections below, each containing
1 mM of the NO donor GSNO by ultrafiltration. Centrifugal concentrators with Amicon Ultra-15
10,000 Da (Millipore) or Vivaspin-20 3,000 Da (Sartorius) molecular weight cut-offs (for STIM2
15-217 and STIM2 15-66, respectively), at 2,500 ´g and 4 °C were used for the buffer exchange
process. Specifically, a 20´20´20-fold or 20´20´20´20-fold buffer exchange was used for the
Ca2+ loaded and depleted conditions, respectively.
The use of 1 mM GSNO was previously used effectively to donate NO and promote S-nitrosylation
of proteins in solution under similar buffer conditions as I employed here (Zhu et al., 2018). A
~500 mM GSNO stock solution was synthesized by dissolving 1.54 g of reduced glutathione into
5.9 mL of 570 mM HCl. The glutathione solution was stirred gently in the dark while 1 mL of 5
M NaNO2 was added to the mixture in a dropwise fashion. The mixture was stirred for an
additional 5 minutes in the dark. After adjusting to pH 6 with 1 M NaOH, the solution was brought
to a final volume of 10 mL using nano-filtered and deionized water (dH2O). A spectrophotometer
set to 335 nm and an extinction coefficient of 0.92 mmol-1 cm-1 was used to determine the
concentration of GSNO. GSNO serial dilutions of 500´, 750´, and 1000´ were prepared to
accurately assess the GSNO stock concentration. Approximately 1 mL aliquots of ~500 mM
prepared GSNO were stored at -80 °C. These stocks were stored in single use aliquots.

2.4 Far-UV circular dichroism (CD) spectroscopy
In order to determine the effect S-nitrosylation on the secondary structure and thermal stability of
the STIM2 full luminal domain (i.e. resides 15-217) and variable N-terminal region (i.e. residues
15-66), far-UV CD spectra were acquired using a Jasco J-815 CD spectrophotometer equipped
with a Jasco PTC-423S temperature controller (Jasco Inc).
To prepare a far-UV CD sample in the Ca2+ loaded condition, protein solutions were exchanged
into buffers at pH = 7.4 containing 10 mM TRIS-HCl, 5 mM CaCl2 and either 1 mM DTT or 1
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mM GSNO using a centrifugal concentrator (see section 2.3). To prepare samples in the Ca2+
depleted condition, protein solutions were incubated with 50 mM EDTA at 4 °C for ~18 hours the
day prior and followed a similar buffer exchange approach as mentioned above, this time in the
absence of 5 mM CaCl2. CD spectra were acquired on 0.5 mg/mL protein samples in a 0.1 cm path
length quartz cuvette.
Far-UV CD spectra were acquired at 20 °C with an average of 3 accumulations between 200 – 240
nm using 8 sec averaging time at each wavelength, 1 nm increments, and 1 nm bandwidth. Protein
spectra were corrected for buffer contributions (10 mM TRIS-HCl ± 5 mM CaCl2 at pH = 7.4).
To assess thermal stability, protein unfolding was monitored by measuring the changes in the 225
nm far-UV CD signal as a function of temperature using an 8 second averaging time, 1 nm
bandwidth and a 1 °C/minute scan rate. The apparent midpoint of temperature denaturation (Tm)
was used as a quantitative indicator of the thermal stability and was extracted by fitting a
Boltzmann sigmoidal equation (see below) to thermal denaturation curves.

𝑌=

𝑀𝑖𝑛 + (𝑀𝑎𝑥 − 𝑀𝑖𝑛)
1 + 10[ 01234 56 × 8019:]

where:
Y = change in CD signal,
Min = minimum CD signal (folded baseline),
Max = maximum CD signal (unfolded baseline),
Tm = temperature of denaturation,
X = temperature.

2.5 8-Anilinonaphthalene-1-sulfonic acid (ANS) binding assay
The relative levels of solvent-exposed hydrophobicity on the full luminal domain of STIM2 under
reducing (control) and S-nitrosylating (experimental) conditions was assessed using ANS, a
fluorescent probe which changes fluorescence intensity when bound to solvent-exposed
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hydrophobic protein regions. A Cary Eclipse spectrofluorimeter (Varian/Aligent Inc) was used to
detect extrinsic ANS fluorescence intensity.
Wildtype STIM2 15-217 protein was exchanged into a buffer without Ca2+ the day following a 50
mM EDTA incubation as described in section 2.3, using a buffer at pH = 7.4 containing 20 mM
TRIS, 150 mM NaCl, and either 1 mM DTT or 1 mM GSNO. 600 µL of 0.143 mg/mL protein
solution was transferred to a quartz cuvette. The emission spectrum of the extrinsic ANS was
acquired from 400 – 600 nm using an excitation wavelength of 372 at 37 °C. The photomultiplier
tube (PMT) was set to 600 V while the excitation and emission slit widths were set to 10 and 20
nm, respectively. 5 mM CaCl2 was titrated into the protein containing cuvette with a 15 minute
incubation after each Ca2+ addition to allow for sufficient binding equilibration. Baseline extrinsic
ANS readings were acquired in buffer only solutions using the identical spectrofluorimeter
parameters and CaCl2 titration regime.

2.6 Dynamic light scattering (DLS)
The contribution of deconvoluted particle size distributions to the light scattering intensity of Ca2+
depleted STIM2 15-217 were determined in a Micro Cuvette (JC501) using a DynaPro Nanostar
dynamic light scattering detector equipped with a 658 nm laser (Wyatt Technology). Distributions
of hydrodynamic radii size were extracted using the autocorrelation function, which correlates
scattered light intensity fluctuations with respect to time (ns-µs) using the regularization
algorithms for polydisperse solutions within the instrument software (Dynamics version 7; Wyatt
Technology).
Wildtype STIM2 15-217 protein was exchanged into control and experimental buffers at pH = 7.4
containing 20 mM TRIS, 150 mM NaCl, and either 1 mM DTT or 1 mM GSNO. The respective
buffer of the sample used for ultrafiltration was loaded into the quartz cuvette, equilibrated for 5
minutes, and then an initial light scattering reading was taken to ensure that the cuvette was dust
free. Protein samples were assessed at final concentrations of 0.46 mg/mL. The protein samples
were centrifuged at 12,000 ´g for 3 minutes and 5 µL aliquots per replicate were taken from the
uppermost portion of the protein sample, thereby avoiding aggregated protein and dust, and loaded
into the quartz cuvette. Following a 5 minute equilibration period, 10 consecutive acquisitions,
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each averaging 5 seconds, were recorded per sample at 37 °C. Low and high cut-offs of 1.5 nm
and 150 nm, respectively, for the hydrodynamic radii size were used in the regularization
deconvolutions for polydisperse solutions.

2.7 Equilibrium chemical denaturation curves
For the chemical denaturation of my proteins, urea was chosen as the chaotropic agent. Urea
reduces the amount of order in the hydration shell around a protein, which leads to protein
denaturation. A Cary Eclipse spectrofluorimeter (Varian/Aligent Inc) was used to detect intrinsic
fluorescence intensity emitted from excited aromatic residues within my protein of interest as a
function of urea concentration. Fluorescence of aromatic residues (i.e. five Trp residues within
STIM2 15-217) is sensitive to the chemical environment, providing a direct readout of protein
denaturation as the aromatic emerges from a buried non-polar environment in the folded state (i.e.
high fluorescence) to an exposed polar environment in the unfolded state (i.e. low fluorescence).
Wildtype and mutant STIM2 15-217 protein samples were exchanged into a buffer with or without
5 mM CaCl2 at pH = 7.4 containing 20 mM TRIS, 150 mM NaCl, and either 1 mM DTT or 1 mM
GSNO by ultrafiltration as described in section 2.3. A series of protein samples were prepared in
urea concentrations ranging from 0 to 6 M from a common stock of 7 M urea. Sample protein
concentrations were kept constant at 5 µM in this series and incubated overnight for ~18-20 hours
in a water bath at 25 °C. The following day, intrinsic fluorescent readings of aromatic residues
Phe, Trp, and Tyr were recorded for each sample using an excitation wavelength of 280 nm and a
slit width of 5 nm. Fluorescent emission spectra were acquired from 300-450 nm with an emission
slit width of 10 nm and a scan rate of 600 nm/minute. Three scans per control (1 mM DTT) and
seven scans per experimental (1 mM GSNO) samples at each urea concentration (0 to 6 M) were
taken to ensure reproducible fluorescent readings within each sample. Equilibrium chemical
denaturation curves were constructed from the change in fluorescence intensity of the last scan at
333 or 330 nm as a function of urea concentration in the Ca2+ loaded and Ca2+ depleted conditions,
respectively. These wavelengths were chosen since they showed the maximal change in
fluorescence intensity between the 0 M and 6 M samples under Ca2+ loaded and Ca2+ depleted
conditions, respectively.
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Wildtype and mutant STIM2 15-217 protein thermodynamic stability parameters including the
change in Gibbs free energy of unfolding in water (DGH2O), denaturant dependence of the
unfolding transition (m-value) and midpoint of chemical-induced denaturation (Cmid) were
assessed using equilibrium chemical denaturation curves and determined via the linear
extrapolation method (Pace, 1986; Pace and Shaw, 2000). Chemical denaturation curves were fit
to a two-state unfolding model through the following set of equations:
DG = −RT ln 𝐾 = DGBCD − 𝑚 × 𝑢𝑟𝑒𝑎 ,
where R is the ideal gas constant, T is temperature in Kelvin, urea is the concentration in M, and
K is the equilibrium constant of two state unfolding. K is related to the fraction of unfolded (FU)
protein as:
𝐹K =

𝐾
1+𝐾

and thus, FU can be solved from rearranging DG = −RT ln 𝐾 as
5DO

𝐹K =

exp ( P3 )
5DO

1 + exp ( P3 )

where DG = DGH2O – m × (urea)
The midpoint of chemical denaturation (i.e. Cmid) was calculated from
DGBCD
𝑚

2.8 Solution nuclear magnetic resonance (NMR) spectroscopy
All NMR experiments were conducted using the Varian INOVA 600 MHz magnet equipped with
a triple resonance HCN cryogenic probe house in the Biomolecular NMR facility at Western
University (London, ON, CAN).
Solution NMR spectroscopy was utilized to determine structural changes associated with Snitrosylation of the full luminal domain of STIM2. Approximately 250 µM of solubilized STIM2
15-217 protein was exchanged in a buffer containing 20 mM TRIS, 100 mM NaCl, 10 mM CaCl2,
and 1 mM GSNO at pH 7.4 as described in 2.3. The solubilized protein sample was supplemented
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with 60 µM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) and 10% (v/v) D2O final
concentrations, bringing the final sample volume to 660 µL. This sample was subsequently
transferred into a Wilmad thin walled (0.38 nm), 5 mm NMR tube. A 1H-15N-heteronuclear single
quantum coherence (HSQC) spectrum for S-nitrosylated STIM2 15-217 protein was obtained
using 256 transients, which revealed strong peaks for ~200 amino acids. The S-nitrosylated spectra
was then compared to the unmodified, reduced spectra by supplementing the sample with 1.5 mM
DTT final concentration to fully remove the NO moiety via reduction before acquiring an HSQC
spectra using the same parameters listed above.
Residue specific chemical shift perturbations (CSP) within the core EFSAM domain were
determined from the S-nitrosylated and DTT-reduced 1H-15N HSQC spectra using previously
assigned STIM2 EFSAM residue chemical shift information (i.e. residues 62-206) (Zheng et al.,
2011a). The computer aided resonance assignment (CARA) software was used to transfer the
assignments from EFSAM to the STIM2 15-217 spectra. Observed residue specific CSP between
S-nitrosylated and control (i.e. DTT-reduced) spectra were calculated from the chemical shift
differences observed in both 1H and

15

N dimensions of each amide peak using the following

equation:

𝑅𝑒𝑠𝑖𝑑𝑢𝑒 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝐶𝑆𝑃 =

[∆𝐻C + 0.14 × ∆𝑁 C ]

where:
∆𝐻C = parts per million (ppm) change in the proton dimension
∆𝑁 C = ppm change in the nitrogen dimension

2.9 STIM2 Mobility Assay
To assess whether my S-nitrosylation protocol alters protein electrophoretic migration either
directly or due to downstream post-translational modifications such as disulfide bond formation, I
examined the mobility of wildtype STIM2 15-217 under reducing and non-reducing conditions by
SDS-PAGE. Note that STIM2 15-217 intramolecular disulfide bond formation between any of
Cys15, Cys53 or Cys60 would alter SDS-PAGE protein mobility due to protein de-linearization.
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Wildtype and mutant STIM2 15-217 protein samples were exchanged at room temperature by
ultrafiltration as described above into three buffers (pH = 8.0) containing 20 mM TRIS and 5 mM
CaCl2 for the oxidized condition, and supplemented with either 1 mM DTT or 1 mM GSNO for
reduced and S-nitrosylated conditions, respectively. The final protein concentration used in this
assay was 0.25 mg/mL for all conditions. Protein samples were separated on a 12.5% (w/v) SDSPAGE gel at 120 V for 90 minutes and subsequently stained with Coomassie blue to visualize
protein mobility.

2.10

Human embryonic kidney (HEK) 293T culture

2.10.1 HEK 293T culture and isolation
HEK 293T adherent cells were cultured in Dulbecco’s modified eagle media (DMEM)
supplemented with high glucose (Wisent), 10% (v/v) fetal bovine serum, 100 µg/mL penicillin
(Wisent), and 100 units/mL streptomycin (Wisent). Cells were grown on 10 cm plates within a
humidified incubator (Panasonic) at 37 °C and 5% (v/v) CO2. When cells reached >70%
confluency after an overnight incubation, the supplemented DMEM was aspirated in a laminar
flow hood and immediately washed with 10 mL of 1´ PBS. After swirling the wash buffer gently
around the plate, the 1´ PBS was removed and 1 mL of 0.25% trypsin (Thermo Scientific Fischer)
supplemented with EDTA (Wisent) was added dropwise throughout the entire surface of the dish.
The plates were manually rocked to ensure complete trypsin contact with all cells and subsequently
placed into a humidified incubator at 37 °C and 5% (v/v) CO2 for ~ 3 minutes. After the brief
incubation, 9 mL of supplemented DMEM was added to the petri dish to attenuate trypsin activity.
The cells were fully detached from the plate and the mixture homogenized by gentle mixing with
a transfer pipette. A ~10% cell passage was used to propagate the cell line where 1 mL of the
trypsinized cell mixture was aliquoted to a sterile petri dish containing 9 mL of fresh, supplemented
DMEM. In order to carry out a ~20 % cell passage used for experimental purposes, 0.75 mL of the
trypsinized cell mixture was aliquoted 6´ into a 6-well (3.5 cm wells) plate each containing 2.25
mL of supplemented DMEM. Cells were maintained in a humidified incubator at 37 °C and 5%
(v/v) CO2 immediately after.
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2.10.2 pCMV6-mCherry-STIM2 recombinant vector transfection
Upon reaching a confluency of ~70 – 80 %, HEK293T cells were transiently transfected with
eGFP-Orai1 and either pCMV6-mCh, wildtype pCMV6-mCh-STIM2, pCMV6-mCh-STIM2
Cys15Ser single mutant, or pCMV6-mCh-STIM2 Cys15Ser/Cys53Ser/Cys60Ser triple mutant
vectors using PolyJet™ transfection reagent (Froggabio) according to the manufacture’s protocol.
An empty pCMV6-mCh vector that only expressed monomeric cherry fluorescence protein in the
absence of STIM2 was also used in some control experiments. In short, for each 3.5 cm well, the
cell culture medium was replaced with 2 mL of supplemented DMEM ~30-60 minutes prior to
transfection. Next, ~500 ng of each eGFP-Orai1 and one pCMV6-mCh-STIM2 vector were diluted
into 50 µL DMEM containing only high glucose. Next, 3 µL of PolyJet™ reagent was diluted into
the same volume mixture in a separate tube. The PolyJet™ mixture was immediately added to the
1 µg DNA mixture and mixed by gently vortexing. The PolyJet™/DNA mixture was subsequently
incubated for ~15 minutes at room temperature. The 100 µL of transfection mixture was added
dropwise to the cell culture dish (3.5 cm well) containing the adherent HEK293T cells in the
culture medium containing supplemented DMEM. Finally, the cells were incubated at 37 °C and
5% (v/v) CO2 for ~24 hours prior to experimentation.
For cells treated with GSNO, HEK293T cells were allowed to express the Orai and STIM2 proteins
for ~6 hours prior to supplementation with 250 µM GSNO final concentration. These cells were
then left overnight in the presence of GSNO to favour S-nitrosylating conditions.

2.10.3 Fura-2 ratiometric fluorescence spectroscopy of live cells
Approximately 24 hours post-transfection, 2 µM Fura-2 acetoxymethly ester (AM) was added to
transfected HEK293T cells and mixed gently by swirling the mixture. The cells were incubated at
37 °C and 5% (v/v) CO2 for ~40 minutes before aspirating the culture media. Two washes were
performed with 0.5 mM CaCl2 supplemented HEPES buffered saline solution (HBSS) comprised
of 140 mM NaCl, 5 mM KCl, 10 mM D-glucose, 1 mM MgCl2 and 10 mM HEPES at pH 7.4. For
cells treated overnight with GSNO, 250 µM GSNO was included in the wash buffer to maintain
the NO abundance. Washed HEK293T cells were mechanically lifted by pipette from the
individual wells with 1.2 mL of 0.5 mM CaCl2 supplemented HBSS with or without the GSNO,
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and transferred into a quartz cuvette. The 1.2 mL cell suspension was incubated at 22.5 °C for 10
minutes using a water bath attached to a Cary Eclipse spectrofluorimeter (Varian/Agilent, Inc.)
In order to assess the relative transfection efficiency, eGFP and mCh fluorescence of the cell
suspension were acquired using excitation wavelengths of 470 and 565 nm, respectively. eGFP
fluorescence emission was recorded between 475 to 575 nm while mCh fluorescence emission was
recorded between 580 to 680 nm. Excitation and emission slit widths were set to 10 and 20 nm,
respectively, while the PMT was set to 650 V.
Fura-2 ratiometric fluorescence measurements of cell suspensions were acquired to determine
basal Ca2+ levels and SOCE. Alternating excitation wavelengths of 340 and 380 nm and an
emission wavelength of 510 nm were used to measure Fura-2 fluorescence at 22.5 °C, using a
PMT of 650 V and an excitation and emission slit widths of 10 and 20 nm, respectively.
Fluorescence intensity at the two excitation wavelengths were acquired for a total 900 s in 1 s
increments. After 100 s of baseline recordings, 1 mM CaCl2 was added to the cell suspension
bathed in 0.5 mM Ca2+. After an additional 100 s, 2 mM EGTA was added to chelate all free Ca2+
in the extracellular solution. At 300 s, 1 µM thapsigargin (TG) was added to passively deplete ER
Ca2+ stores by blocking ER membrane bound SERCA pumps. Finally, at 600 s, 2.5 mM CaCl2 was
added to the suspended cells. All concentrations listed are final concentrations calculated based on
the total cell suspension volume at the time of addition. Data was analyzed by plotting the
fluorescence intensity ratio at 340/380 nm versus time.
Basal Ca2+ levels were measured by averaging raw Fura-2 fluorescence ratios calibrated to Ca2+
concentrations over 50 s in 0.5 mM Ca2+. The TG-induced ER Ca2+ release was measured by
averaging normalized Fura-2 fluorescence ratios (i.e. F/F0) over 300 s after TG addition, while
SOCE was measured by averaging normalized Fura-2 fluorescence ratios after 2 mM Ca2+ addback
over 100 s once the response stabilized. F/F0 was used to determine the fractional increase in
cytosolic Ca2+ over baseline, where F and F0 are the Fura-2 fluorescence ratios after and before
(i.e. baseline) the addition of TG, respectively.
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Ratiometric fluorescence spectroscopy measurements for basal Ca2+ levels were calibrated to the
corresponding Ca2+ concentration (nM) using the following equation (Garcia-Sainz et al., 2010;
Grynkiewicz et al., 1985):
𝐶𝑎C_ = 𝐾` ×

𝑅 − 𝑅abc
𝐹380abc
×
𝑅ade − 𝑅
𝐹380ade

where,
Kd (equilibrium dissociation constant of Ca2+ from Fura-2) was set to 225 nM
(Garcia-Sainz et al., 2010; Grynkiewicz et al., 1985),
R = F340/F380 ratio at any time during experimentation,
Rmin = F340/F380 ratio in the Ca2+ depleted condition,
Rmax = F340/F380 ratio in the Ca2+ saturated condition,
F380min = absolute fluorescence at 380nm in the Ca2+ depleted condition,
F380max = absolute fluorescence at 380nm in the Ca2+ saturated condition.
The Ca2+ saturated condition was attained by adding 0.2% (v/v) Triton X-100 to cell suspensions
post-experimentation, while subsequent addition of 10 mM EGTA (pH = 8) attained the Ca2+
depleted condition. The same Rmax, Rmin, F380max, and F380min values were applied to all
experiments and were determined n = 5 from representative cell suspensions.

2.11

Statistical Analysis

Statistical Analyses involved using an unpaired t-test when comparing between two independent
groups, or a One-way ANOVA followed by Tukey’s post-hoc test when comparing between three
or more independent groups. Tukey’s multiple comparison analysis was used in this study as
opposed to other post-hoc tests because of its conservative estimate of the a-value, which
decreases the probability of obtaining a false positive significance. Because the effect of Snitrosylation on STIM2 function in mammalian cells is fairly unknown, a Tukey’s post-hoc test
was used for a more stringent statistical analysis.
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Chapter 3: Results
3.1 The isolated human STIM2 variable N-terminal region is unstructured
The unbinding of Ca2+ from the EF-hand concomitant with EFSAM structural destabilization are
hallmarks of STIM mediated SOCE initiation (Stathopulos et al., 2006; Zheng et al., 2011a). As a
result, I investigated the effect of Ca2+ on the secondary structure of the full luminal domain of
STIM2 using far-UV CD spectroscopy, normalizing the signal on a per residue basis (i.e. mean
residue ellipticity). Typical of Ca2+-bound EF-hand containing proteins (Ikura, 1996), wildtype
STIM2 15-217 samples loaded with Ca2+ displayed a characteristic a-helical spectrum with two
strong negative ellipticity minima at 208 and ~225 nm. Furthermore, a marked loss in negative
ellipticity at both minima of wildtype STIM2 15-217 protein was observed in samples free of Ca2+,
indicating an attenuated a-helicity (Fig. 3.1A).
The short N-terminal regions of STIM1 and STIM2, upstream of the core EFSAM domains can
profoundly affect Orai1 channel activation kinetics (Zhou et al., 2009). Therefore, I investigated
the secondary structure of the variable STIM2 N-terminal region (i.e. residues 15-66) using farUV CD spectroscopy to probe for potential structural elements. In this assessment, I used the
STIM2 N-terminal region in isolation. Consistent with an online PSIPRED prediction tool
(McGuffin et al., 2000) which showed a very low propensity for regular secondary structure in this
region, Ca2+ loaded wildtype STIM2 15-66 protein displays a characteristic random coil far-UV
CD spectrum indicated by minimal signal between ~240 – 210 nm and abruptly negative ellipticity
at ~200 nm (Fig. 3.1B).
Recent evidence suggests that S-nitrosylation of the variable N-terminal region of STIM1 reduces
SOCE activity (Gui et al., 2018; Zhu et al., 2018). Consequentially, I sought to elucidate whether
S-nitrosylation could affect the a-helicity of the STIM2 full luminal domain and/or promote
alternate secondary structural elements in the STIM2 variable N-terminal region, as both changes
could affect STIM2 mediated SOCE. To promote S-nitrosylation, I exchanged the reduced protein
by ultrafiltration into a buffer containing 1 mM GSNO and no reducing agent. This approach of
high excess NO donor compared to protein concentration is necessary due to the fast reversibility
of S-nitrosylation in the absence of NO and has been successfully applied previously in vitro with
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STIM1 and several other proteins (Bocedi et al., 2004; Feng et al., 2011; Gui et al., 2018; Hao et
al., 2004; Liu et al., 2002; Zhu et al., 2018). Unfortunately, supplementing the protein buffer with
1 mM GSNO caused a high level of absorbance and high tensions exceeding 800 V below 215 nm,
thus producing distorted far-UV CD spectra.
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3.2 Excess NO donor enhances the thermal and thermodynamic stability of
wildtype STIM2 15-217 under Ca2+ deplete and replete conditions
Normally, the majority of STIM proteins remain in a quiescent, inactivated state under replete ER
Ca2+ conditions, with the exception of a subset of STIM2. Upon ER luminal Ca2+ depletion, STIM
proteins destabilize to become activated and redistribute in close apposition to the PM (Brandman
et al., 2007; Liou et al., 2007; Stathopulos et al., 2006; Zhang et al., 2005a). Although determining
changes in secondary structure induced by S-nitrosylation via far-UV CD spectroscopy was not
feasible, I instead examined changes in thermal stability due to excess NO donor in both Ca2+
loaded and depleted conditions at the CD spectroscopy minimum of 225 nm as a function of
temperature, where the high tension was well below 800 V in the presence of 1 mM GSNO. The
apparent midpoint of temperature denaturation (Tm) was used as an indicator of thermal stability
by fitting a Boltzmann Sigmoidal equation to thermal denaturation curves, where a higher Tm is
indicative of a more stable protein. The apparent Tm of Ca2+ loaded wildtype STIM2 15-217 was
significantly increased by ~+4 °C under S-nitrosylating conditions when compared to the control,
unmodified condition (** p < 0.01), suggesting a pronounced stabilization when the majority of
STIM2 is in a quiescent state (Fig 3.2.1A and 3.2.1B). A similar, yet modest increase of ~+2 °C
in apparent Tm of Ca2+ depleted wildtype STIM2 15-217 under S-nitrosylating conditions was
detected (* p < 0.05), indicating a thermal stabilization when the majority of STIM2 is in the active
state (Fig 3.2.1C and 3.2.1D).
To complement and further support my thermal stability data, I conducted equilibrium chemical
denaturation experiments to thermodynamically quantify S-nitrosylation induced stability changes
of wildtype STIM2 15-217 in both the Ca2+ loaded and depleted states. Unlike thermal
denaturation which is irreversible, chemical denaturation of the STIM2 luminal domain is
completely reversible and thus pliable to equilibrium analyses. Consequentially, the change in
Gibbs free energy of unfolding in water (DGH2O) and cooperativity of unfolding (m-value) were
quantified via the linear extrapolation method (Pace and Shaw, 2000) using a two state, folded to
unfolded model, where an increase in DGH2O is indicative of increased protein thermodynamic
stability. The urea concentration where the fraction of unfolded molecules was 50% (i.e. Cmid) was
calculated by dividing DGH2O by m and used as another indicator of relative stability. Expectedly,
in the presence of Ca2+ and excess GSNO, wildtype STIM2 15-217 exhibited an increase in protein
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stability reflected by increased DGH2O (+0.63 kcal/mol; ***p < 0.001) and Cmid (+0.24 M; *p <
0.05) values when compared to the control, unmodified condition (Fig. 3.3A-C). S-Nitrosylating
conditions induced a similar effect in the absence of Ca2+; however, this effect was more
pronounced (DGH2O +1.16 kcal/mol; ***p < 0.001 and Cmid +0.27 M; *p < 0.05) (Fig. 3.3D-F),
suggesting a greater thermodynamic stability enhancement from S-nitrosylation under activating
conditions (i.e. Ca2+ depleted) compared to deactivating conditions (i.e. Ca2+ loaded).
Collectively, these data show that the STIM2 luminal domain thermal and thermodynamic
stabilities are enhanced in the presence of excess NO. Interestingly, excess NO enhances the
thermal stability of STIM2 15-217 in the Ca2+ loaded condition to a larger extent than the Ca2+
depleted condition, whereas the opposite trend is observed in thermodynamic stability
assessments.
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3.3 Ca2+ depleted wildtype STIM2 15-217 is resistant to higher order
oligomerization
Ca2+ depletion induced dimerization and/or oligomerization is a key induction step prior to the
formation of puncta at ER/PM junctions, where STIMs couple to Orai1 and mediate SOCE (Liou
et al., 2007; Liou et al., 2005). Furthermore, molecular and structural differences of both the
EFSAM and variable N-terminal region between STIMs contribute to their distinct
oligomerization propensities, where STIM1 reaches a steady oligomeric state ~70´ faster than
STIM2 (Stathopulos et al., 2009). As a result, I examined whether S-nitrosylation could affect the
oligomerization propensity of the full luminal domain of STIM2, which contains both the variable
N-terminal region and EFSAM domain, through dynamic light scattering (DLS) experiments. The
DLS autocorrelation functions were fit to the regularization algorithm to deconvolute the
polydisperse distribution of hydrodynamic radii sizes in solution. Because light scattering intensity
is proportional to the radius of particle size to the power of 6, the majority (i.e. > 95% by mass) of
solubilized protein is represented by the first peak of distribution sizes. No shift in hydrodynamic
radii size distribution is observed in the presence of excess NO donor for Ca2+ depleted wildtype
STIM2 15-217 protein compared to control, unmodified protein (Fig. 3.3). Assuming globularity,
the theoretical hydrodynamic radius for the ~24.0 kDa STIM2 15-217 monomer is ~2.4 nm. In the
absence of Ca2+, DLS revealed a distribution of sizes centered at ~5 nm, which could represent a
mixture of monomers, dimers and higher order oligomers. This distribution of sizes was largely
unaffected by the presence of 1 mM GSNO, in contrast to previous studies using the luminal
domain of STIM1 (i.e. residues 23-213) that showed a shift to smaller hydrodynamic sizes in the
presence of GSNO (Zhu et al., 2018). It should be noted that the Ca2+ depleted luminal domain of
STIM1 exhibits a main distribution of hydrodynamic radii centered at ~10 nm under similar
experimental conditions (Zhu et al., 2018), making the GSNO-dependent shifts to monomeric radii
easily detectable using the identical experimental parameters.
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3.4 Excess NO donor minimally affects the level of solvent-exposed
hydrophobicity of wildtype STIM2 15-217
Oligomerization induced by Ca2+ depletion is driven by an increase in exposed hydrophobic
regions of STIM EFSAM domains (Stathopulos et al., 2006). Therefore, I sought to determine the
level of solvent exposed hydrophobicity of Ca2+ loaded and depleted STIM2 15-217 in the
presence and absence of excess NO donor using the extrinsic fluorescent probe ANS. When ANS
binds to solvent-exposed hydrophobic protein regions, the extrinsic fluorescence emission
spectrum of ANS exhibits higher fluorescence and a blue-shifted peak maximum. Thus, a lower
fluorescence intensity and a peak maximum at higher wavelengths is indicative of a protein
conformation with less exposed hydrophobic residues. Here, incubating ANS in the presence of
wild-type STIM2 15-217 under reducing conditions (i.e. 1 mM DTT) and in the absence of Ca2+
resulted in higher ANS fluorescence intensity and concomitant shift of the peak maximum to lower
wavelength. The addition of 5 mM CaCl2 decreased the fluorescence intensity and shifted the peak
maximum to a higher wavelength, indicative of a conformational change that decreased the
solvent-exposed hydrophobicity (Fig. 3.4A). Similar ANS experiments performed in the presence
of 1 mM GSNO instead of 1 mM DTT showed analogous fluorescence intensities and locations of
the peak maxima (Fig. 3.4B). The ANS fluorescence properties in the presence of 1 mM GSNOor DTT-containing buffer was insensitive to 5 mM CaCl2.
Collectively, my ANS experiments suggest that excess NO minimally affects the level of solventexposed hydrophobicity of Ca2+ depleted wildtype STIM2 15-217 and that the addition of 5 mM
CaCl2 to these samples induces a conformational change with less solvent-exposed
hydrophobicity, both in the presence and absence of excess GSNO.
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3.5 Excess NO induces chemical shift perturbations on the STIM2 EFSAM
core, far from the N-terminal Cys residues
Having discovered that excess NO donor enhances the stability of the luminal STIM2 domain, but
does not affect the exposed surface hydrophobicity and oligomerization, I next used solution
nuclear magnetic resonance (NMR) spectroscopy to confirm that protein structural changes
underlie the observed stabilization. In the presence of Ca2+ and under reducing conditions, the
wildtype STIM2 15-217 1H-15N-HSQC spectrum exhibited highly dispersed amide 1H(15N)
crosspeaks ranging from ~11.0 to 6.5 ppm in the 1H dimension, indicative of a well-folded
conformation (Fig. 3.5A). After exchange of the protein into a 1 mM GSNO containing buffer, the
spectrum showed numerous 1H(15N) chemical shift perturbations (CSP)s, indicative of structural
changes. To determine whether the structural changes were localized on the variable N-terminal
region or on the EFSAM core domain, I compared the 1H-15N-HSQC spectrum in the presence of
1 mM DTT to the previously assigned spectrum of Ca2+-loaded STIM2 EFSAM (i.e. residues 62206) (Zheng et al., 2011a) [Biological Magnetic Resonance Bank (BMRB) accession number
17289]. Most 1H(15N) resonance signals of the full STIM2 15-217 luminal domain were the same
as those observed for the EFSAM in isolation (i.e. residues 62-206), suggesting this core sensing
domain adopts a similar conformation in the presence of the variable N-terminal and C-terminal
extensions.
Given these spectral similarities, I determined the total CSP for each EFSAM 1H(15N) resonance
within the full STIM2 15-217 luminal domain caused by the excess GSNO (Fig. 3.5B). Mapping
the CSPs relative to the EFSAM amino acid sequence revealed two major clusters of residuespecific perturbations: one on the entering helix of the canonical EF-hand and a second on the
exiting helix of the non-canonical EF-hand and the adjacent SAM linking helix. Mapping the CSPs
on the three-dimensional (3D) backbone ribbon and surface structures of STIM2 EFSAM [Protein
Data Bank (PDB) accession identification 2L5Y] revealed that the majority changes were localized
to one face of the domain (Fig. 3.5C and 3.5D). The three Cys residues that can undergo Snitrosylation (i.e. Cys15, Cys53 and Cys60) are located in the variable N-terminal region of the
luminal domain, outside the EFSAM core. Thus, the data suggest that excess GSNO causes global
structural changes within the luminal domain, likely due to an interaction between the modified
variable region containing three Cys residues and one side of the EFSAM core.
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3.6 Excess NO donor enhances the thermal and thermodynamic stability of
STIM2 15-217 in a Cys-specific manner
Having found that excess GSNO causes structural perturbation far from the variable N-terminal
region of STIM2 that contains the Cys residues, I next assessed whether the stabilization observed
was Cys specific. S-nitrosylation of specific Cys residues is known to affect stability, structure,
localization and function of the protein modified (Gould et al., 2013). S-Nitrosylation of Cys49
and Cys56 in STIM1 was found to suppresses Ca2+ sensitivity and inhibit SOCE (Zhu et al., 2018).
STIM2 not only contains Cys residues at similar positions in the variable N-terminal region (i.e.
Cys53 and Cys60), but also has an additional Cys residue at the N-terminus (i.e. Cys15), which I
posit is also susceptible to S-nitrosylation. Accordingly, S-nitrosylation of this unique Cys residue
may underlie distinct structural and functional differences between STIM homologs. To test
whether the stabilization observed for STIM2 in the presence of excess NO occurs in a Cysspecific manner, I created a series of Cys to Ser mutant STIM2 15-217 proteins. In total, I
expressed and purified five different mutant proteins: Cys15Ser, Cys53Ser, Cys60Ser (single
mutants), Cys53Ser/Cys60Ser (double mutant) and Cys15Ser/Cys53Ser/Cys60Ser (triple mutant).
For all variants, protein expression levels and purities were similar to wild-type.
First, I assessed the thermal stability of each of the Ca2+-loaded proteins in the presence and
absence of excess GSNO. The Cys15Ser and Cys53Ser single mutants minimally affected the
thermal stability of STIM2 15-217, with the proteins showing only marginally higher Tm values of
~+0.2 and +0.4 °C, respectively, compared to wild-type (Fig. 3.6.1). The Cys60Ser,
Cys53Ser/Cys60Ser and Cys15Ser/Cys53Ser/Cys60Ser mutations affected stability to a larger
extent, with Tm values indicating destabilization of ~-1.2, -3.2 and -2.4 °C, respectively, compared
to wild-type (Fig. 3.6.1).
Next, I assessed the thermal stability of these proteins in the presence of 1 mM GSNO. The
difference in Tm between S-nitrosylation promoting and reducing conditions (i.e. DTm) for each
protein variant was calculated as a measure of the effect of S-nitrosylation on protein stability.
Recall that excess GSNO induced a thermal stabilization of Ca2+ loaded wildtype STIM2 15-217
of ~+4.1 °C (Fig. 3.2.1A and 3.2.1B). The same data is reproduced here as a readily accessible
reference to the mutant Tm data (Fig. 3.6.2A and 3.6.2B). Remarkably, excess GSNO induced a
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smaller increase in Tm of only ~+2.2 °C for the Cys15Ser mutant protein compared to wild-type,
indicating that the unique Cys15 of STIM2 15-217 plays a role in the GSNO-mediated stabilization
(Fig. 3.6.2C and 3.6.2D). In contrast, the Cys53Ser and Cys60Ser single mutant proteins showed
no apparent enhancement in stability with Tm values significantly decreasing by ~-1.0 °C (Fig.
3.6.2E-H). Both the Cys53Ser/Cys60Ser double mutant and Cys15Ser/Cys53Ser/Cys60Ser
thermal stabilities appeared largely insensitive to excess GSNO with Tm values marginally
increasing by ~+0.1 and +0.4 °C, respectively (Fig. 3.6.2I-L).
Collectively, these data show that mutation of Cys53 or Cys60, which are conserved with Cys
residues at analogous positions in STIM1, abrogates the GSNO-mediated thermal stabilization.
However, the Cys15, which is unique to STIM2, also contributes to GSNO-mediated stabilization
when the Cys53 and/or Cys60 sulfhydryls remain modifiable. Importantly, Ca2+ loaded
Cys15Ser/Cys53Ser/Cys60Ser STIM2 15-217 does not undergo a significant change in thermal
stability, indicating a Cys-specific response to the NO donor.
The thermal stability assessments were performed in the presence of Ca2+ where GSNO caused a
larger apparent stabilization compared to the absence of Ca2+ for the wild-type protein. Next, I
performed equilibrium chemical denaturation experiments using the Cys variants to quantify the
stability changes in the absence of Ca2+ where GSNO caused a larger thermodynamic stabilization
for the wild-type protein. Here, I used the difference in the DGH2O and Cmid (i.e. DDGH2O and DCmid)
between S-nitrosylation promoting and reducing conditions as indicators of the stability changes.
Excess GSNO induced an increase DGH2O for Ca2+ depleted wildtype STIM2 15-217 of ~+1.2 kcal
mol-1, which corresponded to an increase in Cmid of ~+0.3 M urea (Fig. 3.2.2D-F). The same data
are reproduced here as a readily accessible reference to the mutant data (Fig. 3.6.3A-C). The
Cys15Ser protein showed less pronounced stabilization compared to wild type, reflected by a
DCmid of only ~+0.2 M and DDGH2O of ~+0.5 kcal mol-1 (Fig. 3.6.3D-F). As observed with the
Ca2+-loaded thermal stability assessments, the Ca2+-depleted Cys49Ser/Cys60Ser double mutation
largely abrogated any Cys15-mediated stabilization in the presence of excess GSNO (Fig. 3.6.2GI), showing a DDGH2O of ~+0.1 kcal mol-1. Interestingly, DCmid for this double mutant was slightly
increased (+0.1 M; p < 0.05) due to lower cooperativity of unfolding (m-value). The Ca2+ depleted
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Cys15Ser/Cys53Ser/Cys60Ser triple mutant did not exhibit any GSNO-mediated differences in
DGH2O or Cmid (Fig. 3.6.3J-L).
Collectively, these data demonstrate that the stability of Ca2+-depleted STIM2 15-217 is enhanced
in the presence of excess NO, and the greatest stabilization occurs when all native Cys are available
for modification. Moreover, this enhanced stability is a Cys-specific response, and the unique
Cys15 residue contributes to stabilization only when the conserved Cys53 and Cys60 residues are
available for S-nitrosylation. These trends are similar to those observed using the Ca2+ loaded
proteins and assessed by temperature denaturation.
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Table 3.1. Apparent denaturation midpoint (Tm) of wildtype, single-, double-, and triplemutant STIM2 15-217 protein with or without Ca2+ and/or GSNO.
STIM2 15-217
Condition
Apparent Tm (°C)
(Mean ± SEM)
Ca2+ Depleted
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

51.71 ± 0.48
53.41 ± 0.13 *
+1.70 ± 0.50

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

63.16 ± 0.12
67.25 ± 0.65 **
+4.09 ± 0.66

Single-Mutant
Cys15Ser

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

63.35 ± 0.07
65.77 ± 0.51 **
+2.41 ± 0.52

Single-Mutant
Cys53Ser

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

63.63 ± 0.03
62.61 ± 0.17 **
-1.02 ± 0.18

Single-Mutant
Cys60Ser

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

62.03 ± 0.04
60.96 ± 0.18 **
-1.07 ± 0.19

Double-Mutant
Cys53/60Ser

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

59.98 ± 0.07
60.12 ± 0.08 (n.s.)
+0.14 ± 0.11

Triple Mutant
Cys15/53/60Ser

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

60.81 ± 0.12
61.16 ± 0.08 (n.s.)
+0.35 ± 0.14

Wildtype

Statistical analyses were performed using a student’s t-test.
*p < 0.05, **p < 0.01 versus 1 mM DTT control.
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Table 3.2. Thermodynamic stability values for wildtype and mutant STIM2 15-217 with or
without Ca2+ and/or GSNO.
STIM2 15-217
Condition
m-value
Cmid
DGH2O
[kcal mol-1]
(Mean ± SEM)

[kcal mol-1M-1]
(Mean ± SEM)

Ca2+ Loaded
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

6.87 ± 0.02
7.49 ± 0.06 ***
+0.63 ± 0.06

2.05 ± 0.11
2.00 ± 0.17

3.34 ± 0.01
3.58 ± 0.06 *
+0.24 ± 0.06

Ca2+ Depleted
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

4.82 ± 0.02
5.98 ± 0.06 ***
+1.16 ± 0.06

1.69 ± 0.08
1.92 ± 0.19

2.85 ± 0.01
3.11 ± 0.03 **
+0.27 ± 0.03

Single-Mutant
Cys15Ser

Ca2+ Depleted
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

6.22 ± 0.02
6.71 ± 0.02 **
+0.49 ± 0.06

1.78 ± 0.12
1.82 ± 0.27

3.47 ± 0.01
3.69 ± 0.03 **
+0.22 ± 0.03

Double-Mutant
Cys53/60Ser

Ca2+ Depleted
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

3.54 ± 0.01
3.63 ± 0.03 (n.s.)
+0.10 ± 0.04

1.50 ± 0.07
1.47 ± 0.08

2.36 ± 0.01
2.48 ± 0.02 *
+0.12 ± 0.02

Triple Mutant
Cys15/53/60Ser

Ca2+ Depleted
1 mM DTT (n=3)
1 mM GSNO (n=3)
D GSNO – DTT:

3.41 ± 0.17
3.40 ± 0.15 (n.s.)
+0.01 ± 0.23

1.54 ± 0.17
1.58 ± 0.11

2.39 ± 0.04
2.38 ± 0.02 (n.s.)
+0.01 ± 0.02

Wildtype

[M]
(Mean ± SEM)

Statistical analyses were performed using a student’s t-test.
*p < 0.05, **p < 0.01, ***p < 0.001 versus. 1 mM DTT control.
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3.7 Excess NO prevents intramolecular disulfide bond formation of the
STIM2 15-217 luminal domain
Thiols that have undergone S-nitrosylation are intrinsically unstable and have the propensity to
form disulfide bonds in the presence of an electron acceptor, such as reduced metals and thiols
(Arnelle and Stamler, 1995; Wolhuter et al., 2018). Additionally, GSNO not only acts as an NO
donor, but also provides a glutathione group that could covalently link to a thiol under oxidizing
conditions. Consequentially, it is possible that disulfide bond formation or S-glutathionylation,
rather than S-nitrosylation, caused the augmented stability observed herein for STIM2 15-217.
Therefore, I next checked for the possibility of disulfide bond formation and S-glutathionylation
using an SDS-PAGE mobility shift assay.
STIM2 15-217 migrates in SDS-PAGE gels slightly above its theoretical molecular weight of
~24.0 kDa due to a high enrichment of acidic residues, similar to STIM1 (Zhu et al., 2018). The
presence of intramolecular disulfide bonds would increase the compactness of the protein chain
resulting in higher mobility in SDS-PAGE gels. In contrast, S-glutathionylation would increase
the molecular weight of the protein by as much as 918 Da (i.e. 3 moieties at 306 Da), decreasing
mobility in SDS-PAGE. I prepared three wild-type STIM2 15-217 samples using the same
ultrafiltration procedure I routinely used for GSNO exchange (see Section 2.3): one sample in 1
mM DTT (reducing condition), one sample in 1 mM GSNO (S-nitrosylating condition) and one
sample containing neither GSNO nor DTT (non-reducing condition). SDS PAGE of these samples
revealed a migration shift only for the protein sample in the non-reducing condition, likely
reflecting intramolecular disulfide bond formation (Fig. 3.7). As a negative control, the
Cys15Ser/Cys53Ser/Cys60Ser triple mutant protein was processed in the identical manner. In
contrast to the increased mobility observed for the wild-type protein under non-reducing
conditions, the migration of the triple mutant protein remained unchanged. Note that samples were
not boiled for this experiment due to the labile nature of S-nitrosylation, and samples were
separated by empty lanes to minimize contamination of GSNO and DTT across lanes.
Collectively, these data indicate that 1 mM GSNO is likely to favour S-nitrosylation of STIM2 15217 over oxidation and S-glutathionylation under the buffer conditions used in this research.
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3.8 Excess NO suppresses STIM2-mediated basal Ca2+ homeostasis and
SOCE in live HEK293T cells
After establishing that excess GSNO causes a Cys-dependent thermodynamic stabilization
concomitant with structural perturbations in the STIM2 15-217 luminal domain that is likely due
to S-nitrosylation, I next investigated whether this effect has any functional consequences. Fura-2
ratiometric fluorimetry was used to probe basal Ca2+ and SOCE in HEK293T cells transiently cooverexpressing enhanced green fluorescent protein tagged Orai1 (i.e. eGFP-Orai1) and monomeric
cherry fluorescent protein tagged STIM2 (i.e. mChSTIM2). Together, STIM2 and Orai1 can form
and gate Ca2+ channels on the PM.
Cells loaded with Fura-2 (see Section 2.10) were bathed in HBSS media supplemented with 0.5
mM Ca2+ 24 hours after transfection, transferred into a quartz cuvette and temperature equilibrated
for 10 minutes. Following this equilibration time, basal Ca2+ levels were measured by averaging
Fura-2 fluorescence ratios over 50 s. Consistent with previous studies, cells overexpressing wildtype mChSTIM2 with eGFP-Orai1 had significantly higher basal Ca2+ levels when compared to
control cells overexpressing monomeric cherry fluorescence protein (mCh) with eGFP-Orai1 (i.e.
~210 nM compared to ~117 nM, respectively; p < 0.001). Overnight incubation of HEK293T cells
overexpressing wild-type mChSTIM2 and eGFP-Orai1 with 250 µM GSNO supplemented into
the growth medium muted the basal Ca2+ level enhancement (Fig. 3.8.1A and 3.8.1B). To
determine whether this inhibition of basal Ca2+ was dependent on Cys15, Cys53 and Cys60 of
STIM2, similar experiments were performed using a Cys15Ser/Cys53Ser/Cys60Ser triple mutant
mChSTIM2. Basal Ca2+ levels of HEK293T cells expressing the triple mutant STIM2 protein and
eGFP-Orai1 did not significantly differ from those in control cells overexpressing mCh and eGFPOrai1 either in the presence or absence of GSNO (Fig. 3.8.1A and 3.8.1B).
Increased basal Ca2+ levels mediated by STIM2 are accompanied by higher intracellular Ca2+ store
concentrations within the ER (Brandman et al., 2007). Thus, I next assessed whether cells
overexpressing mChSTIM2 had elevated ER Ca2+ store levels and whether GSNO affected this
phenomenon. To assess ER Ca2+ levels, EGTA was added to the cell bathing medium to chelate
all extracellular Ca2+. Subsequently, 2 µM TG was used to passively deplete ER Ca2+ stores by
blockade of SERCA pumps. Since basal Ca2+ levels differed among groups, the Fura-2 response
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was normalized as F/F0 to determine the fractional increase in cytosolic Ca2+ over baseline induced
by TG, where F and F0 are the Fura-2 fluorescence ratios after and before (i.e. baseline) the addition
of TG, respectively. Consistent with my observation that cells overexpressing wild-type
mChSTIM2 and eGFP-Orai1 exhibited higher basal Ca2+ levels, this same group displayed a
significantly higher TG-induced ER Ca2+ release when compared to control cells overexpressing
mCh and eGFP-Orai1. Furthermore, overnight treatment with 250 µM GSNO attenuated this
enhancement back to control levels (Fig. 3.8.2A and 3.8.2B). Also in agreement with my basal
Ca2+ measurements, the TG-induced ER Ca2+ release from cells overexpressing the
Cys15Ser/Cys53Ser/Cys60Ser triple mutant mChSTIM2 and eGFP-Orai1 did not significantly
differ from the control cells and was not affected by GSNO.
While STIM2 chiefly regulates basal Ca2+ levels, it also mediates SOCE, albeit to a lesser degree
compared to STIM1 in HEK293T cells (Emrich et al., 2019). To assess SOCE, 2 mM of net Ca2+
was added back to the extracellular medium to elicit influx into the cytosol through PM Orai1
channels. As anticipated, cells overexpressing wild-type mChSTIM2 and eGFP-Orai1 displayed
significantly higher levels of SOCE compared to control cells overexpressing mCh and eGFPOrai1 (Fig. 3.8.2A and 3.8.2C). As observed with basal and ER stored Ca2+ release, overnight
incubation of wild-type mChSTIM2 and eGFP-Orai1 expressing cells with 250 µM GSNO
abrogated this SOCE enhancement (Fig. 3.8.2A and 3.8.2C). Cells overexpressing the
Cys15Ser/Cys53Ser/Cys60Ser triple mutant mChSTIM2 and eGFP-Orai1 failed to elicit SOCE
above levels observed in the control group with and without GSNO treatment.
Note that similar experiments were attempted with single Cys15Ser and double
Cys53Ser/Cys60Ser mutant versions of mChSTIM2. However, for unknown reasons, a low
proportion of these cell suspensions responded to TG (i.e. < 20%), and cell preparations that did
respond exhibited atypical release from ER stores and high variability in the level of SOCE. Thus,
these groups were not included in the analysis.
To ensure that the changes in Fura ratios mediated by mChSTIM2 and eGFP-Orai1 were not due
to differences in protein expression levels, eGFP and mCh fluorescence emission spectra of the
cell suspensions were acquired. My laboratory has previously shown that mChSTIM1 fluorescence
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correlates with protein expression levels via western blotting (Zhu et al., 2018). Here, eGFP-Orai1
fluorescence did not differ significantly among all groups tested, regardless of GSNO incubation
(Fig. 3.8.2D). Due to the cytosolic localization, cells expressing mCh showed significantly higher
mCh fluorescence compared to cells expressing mChSTIM2 proteins that were inserted into the
ER membrane (Fig. 3.8.2E). However, GSNO did not affect the expression levels of either the
mCh or mChSTIM2 proteins.
Taken together, these results demonstrate that GSNO alters STIM2-mediated basal Ca2+
homeostasis concomitant with decreased ER Ca2+ stores, as well as SOCE activation, which is
consistent with the GSNO mediated thermal and thermodynamic stabilization of the STIM2
luminal domain. Additionally, these cell experiments reveal a remarkable sensitivity of STIM2
function to variations in the three Cys residues located in the luminal domain.
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Chapter 4: Discussion
4.1. Summary
Hyperactivation of the STIM-mediated SOCE pathway results in dysregulated Ca2+ homeostasis,
underlying many pathological conditions including cardiovascular and neurodegenerative diseases
(Luo et al., 2012; Secondo et al., 2018). Recent evidence demonstrates that S-nitrosylating
conditions increase STIM1 full luminal domain protein stability, suppress Ca2+ dependent STIM1
oligomerization and inhibit SOCE by maintaining a quiescent STIM1 luminal domain
conformation by promoting interactions between the variable N-terminal region and the EFSAM
core (Zhu et al., 2018). Here, my data reveals that the STIM2 luminal domain is also sensitive to
S-nitrosylation promoting conditions, exhibiting changes in stability, structure and function in the
presence of excess NO donor. In contrast to STIM1 which contains two modifiable Cys residues,
STIM2 contains three modifiable Cys residues within the luminal domain (i.e. Cys49 and Cys56
compared to Cys15, Cys53 and Cys60, respectively). My data suggest that all three of these Cys
residues play a role in modulating STIM2 biophysical attributes due to S-nitrosylation.
Specifically, the NO donor GSNO promotes a STIM2 luminal domain migration on SDS-PAGE
that is most consistent with S-nitrosylation, when compared to protein with intramolecular
disulfides or the expected migration of S-glutathionylated protein. Further, I show that these Snitrosylation favouring conditions thermally and thermodynamically stabilize the domain via new
or changed interactions between the STIM2 variable N-terminal region and one face of the
EFSAM core. Importantly, the effects at the biophysical and structural levels were Cys-dependent,
and loss of the unique Cys residue to STIM2 (i.e. Cys15) attenuated excess GSNO induced
stabilization compared to wildtype protein. Interestingly, Cys15 alone failed to induce STIM2
luminal domain stabilization in the presence of excess GSNO, suggesting that Cys15 mediates an
increase in protein stability that is dependent on Cys53 and Cys60 residues in the presence of
excess NO. I propose that, under S-nitrosylating conditions, Cys53 and Cys60 work in concert to
interact with one side of the EFSAM core (i.e. residues 62-206) such that Cys15 is brought into
close apposition to the same region, facilitating further interactions and protein stabilization.
Consistent with my work using the isolated STIM2 luminal domain, I found that GSNO attenuates
full-length STIM2 mediated basal Ca2+ homeostasis and SOCE in mammalian HEK293T cells.
Interestingly, full length STIM2 protein with all three modifiable Cys residues in the variable N87

terminal region mutated to Ser (i.e. Cys15Ser/Cys53Ser/Cys60Ser) failed to elicit SOCE and
increase basal Ca2+ levels associated with increased ER Ca2+ stores, highlighting the functional
sensitivity of the molecule to variations at these residue positions. Ultimately, my work suggests
that excess GSNO promotes S-nitrosylation, which can attenuate STIM2-mediated basal Ca2+
levels and SOCE by stabilizing the full luminal domain via specific interactions between
nitrosylated Cys residues within the variable N-terminal region and one face of the EFSAM core.

4.2. Excess NO promoted protein S-nitrosylation
S-Nitrosylation is a transient and reversible post-translational modification, where an NO moiety
is covalently attached to the sulfur atom of a Cys residue to form S-nitrosothiols (i.e. –SNO
groups). S-Nitrosothiol formation is thought to occur via a recombination between a thiyl radical
and NO or via oxidation of NO to N2O3 in the presence of an electron acceptor (Broniowska and
Hogg, 2012; Madej et al., 2008). While the exact mechanism by which endogenous S-nitrosothiols
form remains largely unknown, protein S-nitrosylation in the presence of NO is well supported by
several lines of evidence. First, different types of NO donors have been used to demonstrate Snitrosylation of STIM1 including sodium nitroprusside (SNP) and GSNO. Second, in vitro NO
donor promoted S-nitrosylation occurs in a concentration-dependent manner. In other words, lower
concentrations (i.e. 1 mM) of SNP were shown to have a smaller biophysical effect than higher
concentrations (i.e. 2 mM) (Zhu et al., 2018). Third, neuronal NOS was shown to co-localize with
its target protein in neuronal synapses to produce NO thereby promoting protein S-nitrosylation
(Dejanovic and Schwarz, 2014). Fourth, in vivo knockout mice models of neuronal NOS decreased
cellular NO levels concomitant with a decrease in protein S-nitrosylation (Burger et al., 2009).
Fifth, nNOS knockout cardiomyocytes show no evidence for STIM1 S-nitrosylation whereas
cardiomyocytes from wild-type mice show S-nitrosylated STIM1 (Gui et al., 2018). Thus, the
presence of NO promotes protein S-nitrosylation both in vitro and in vivo, despite the chemical
mechanism being poorly understood.
In my current study, I utilized molar excess amounts of the NO donor, GSNO, to promote Snitrosylation of STIM2 at Cys15, Cys53, and Cys60 in vitro. The use of excess GSNO as a
treatment to successfully promote S-nitrosylation has been previously used in the literature (Bocedi
et al., 2004; Erickson et al., 2015; Feng et al., 2011; Hao et al., 2004) and by my lab (Zhu et al.,
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2018). Despite the well-established use of GSNO treatment to promote S-nitrosylation induced
structural and functional effects on proteins, reports suggest that disulfide bond formation, rather
than S-nitrosylation, could underlie the observed changes in protein function (Wolhuter et al.,
2018). Moreover, GSNO treatment can also promote another protein post-translational
modification, S-glutathionylation, by donating a glutathione moiety. However, S-glutathionylation
by GSNO is a much slower reaction and is thermodynamically unfavourable (Hawkins et al.,
2010). Additionally S-glutathionylation has been shown to destabilize the luminal domain of
STIM1 (Hawkins et al., 2010). Nevertheless, in order to confirm that the biophysical and
functional effects in my study were due to excess GSNO promoted S-nitrosylation and not
disulfide bond formation or S-glutathionylation, a mobility assay was devised, relying on the
phenomena that intramolecular disulfide bonds increase protein mobility while S-glutathionylation
decrease protein mobility (Betz, 1993). For this mobility assay, I used the same ultrafiltration
process to exchange the samples into reducing, non-reducing and S-nitrosylation favouring
conditions. Indeed, GSNO treatment did not affect wildtype STIM2 15-217 protein mobility,
suggesting that GSNO prevented intramolecular disulfide bond formation and S-glutathionylation.
On the contrary, the absence of DTT or GSNO (i.e. buffer alone; non-reducing conditions)
noticeably increased the mobility of wildtype STIM2 15-217 protein, consistent with the formation
of an intramolecular disulfide bond (Fig. 3.7). Therefore, GSNO treatment prevented wildtype
STIM2 15-217 intramolecular disulfide bond formation, and there was no evidence for decreased
mobility caused by S-glutathionylation, collectively suggesting that the biophysical and functional
effects detected in my study were mediated by STIM2 S-nitrosylation due to the presence of excess
NO.
My data demonstrating that luminal domain S-nitrosylation by GSNO treatment, rather than
disulfide bond formation or S-glutathionylation, is the primary modification regulating STIM2
structure and function is well supported by published literature. Disulfide bond formation in the
luminal domain of STIM1 (i.e. Cys49-Cys56) has been demonstrated to enhance, rather than
inhibit, STIM1 mediated SOCE (Prins et al., 2011). Similarly, S-glutathionylation promotes
STIM1-mediated SOCE (Hawkins et al., 2010). Consistent with the results of my mobility assay,
STIM1 proteins from heart tissue homogenates of wildtype mice, but not eNOS-/- or nNOS-/- mice,
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show a mobility shift under non-reducing conditions, in agreement with intramolecular disulfide
bond formation (Gui et al., 2018).

4.3. Biophysical comparison of the full luminal domain between STIM
homologs in the presence of NO
The Ca2+ sensing luminal domain of STIM2 (i.e. 15-217) becomes activated upon ER luminal Ca2+
depletion and adopts a destabilized conformation, which ultimately triggers downstream SOCE
activation (Stathopulos et al., 2013; Stathopulos et al., 2009; Stathopulos et al., 2008b; Zheng et
al., 2008). Thus, modifications affecting luminal domain stability can profoundly impact STIM2
activity.
My investigation demonstrated that the highly a-helical structure of the full luminal domain of
STIM2 is attenuated upon Ca2+ depletion (Fig. 3.1A), congruent with previous studies
demonstrating that a loss in a-helical structure is associated with STIM2 activation (Stathopulos
and Ikura, 2013b; Stathopulos et al., 2009; Zheng et al., 2008). In agreement with my secondary
structure analysis, Ca2+ depletion markedly decreased the thermal and thermodynamic stability of
wildtype STIM 15-217. Treatment with GSNO to promote S-nitrosylation at Cys15, Cys53 and
Cys60 significantly increased both the thermal and thermodynamic stability compared to the
respective reduced sulfhydryl condition in both Ca2+ replete and deplete conditions (Fig. 3.2.1 and
3.2.2). The increased thermodynamic stability is more apparent under Ca2+ depleted states, when
the majority of STIM2 molecules become activated. To confirm that the enhanced stabilization
was mediated by S-nitrosylation of Cys15, Cys53, and Cys60, a triple mutant STIM2 15-217
protein with all Cys residues mutated to Ser (i.e. Cys15Ser/Cys53Ser/Cys60Ser) was created,
effectively removing all modifiable sulfhydryls. Despite the triple mutation producing an inherent
thermal and thermodynamic destabilization compared to wildtype protein, the thermal and
thermodynamic stability of this triple mutant STIM2 15-217 was not affected by GSNO treatment
(Fig. 3.6.2F 3.6.2L and Fig. 3.6.3D 3.6.3H 3.6.3L), suggesting that the excess GSNO induced
stabilization reported in this thesis is Cys specific.
Because equilibrium chemical denaturation of the STIM2 luminal domain is reversible,
thermodynamic stability parameters, such as DGH2O, were estimated using a two-state, folded to
unfolded model. The Feng and Stathopulos groups have previously employed the same
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experimental model to compare the thermodynamic stability of the full luminal domain of STIM1
(i.e. residues 23-213) under reducing and S-nitrosylating conditions (i.e. residues 23-213) (Zhu et
al., 2018), thus making STIM1-STIM2 comparative analyses feasible. In the absence of Ca2+,
STIM2 EFSAM retains a well folded structure compared to unstructured STIM1 EFSAM (Zheng
et al., 2008). Moreover, previous urea-induced kinetics of unfolding studies indicate that Ca2+
loaded STIM1 EFSAM unfolds significantly faster than STIM2 EFSAM (Stathopulos et al., 2009).
In agreement with these phenomena, reduced STIM2 15-217 displays a higher DGH2O compared
to reduced STIM1 23-213, in both Ca2+ replete (i.e. 6.87 kcal/mol versus 5.91 kcal/mol,
respectively) and deplete (i.e. 4.82 kcal/mol versus 1.73 kcal/mol) conditions (Zhu et al., 2018).
Interestingly, excess NO enhanced the thermodynamic stability of the STIM1 luminal domain to
a larger degree compared to the STIM2 luminal domains in both Ca2+ replete (i.e. DDGH2O = +1.9
kcal/mol versus DDGH2O = +0.63 kcal/mol) and deplete (i.e. DDGH2O = +1.6 kcal/mol versus
DDGH2O = +1.2 kcal/mol) conditions (Zhu et al., 2018).
GSNO promotes S-nitrosylation of both Cys49 and Cys56 in STIM1, which enhances the
thermodynamic stability of the full luminal domain (i.e. residues 23-213) (Zhu et al., 2018).
Interestingly, either Cys49Ser or Cys56Ser STIM1 23-213 single mutations abrogate any GSNOmediated detectable changes in thermal stability of the isolated luminal domain; however,
separately integrating these single mutations into full-length STIM1 diminishes the NO-mediated
suppression of CRAC entry and simultaneously introducing both mutations is required to
completely abolish the NO-mediated suppression of CRAC entry measured using whole cell patch
clamp electrophysiology experiments (Gui et al., 2018). Based on my data, this stabilization of
STIM1 is analogous to that of STIM2, despite STIM2 containing an additional modifiable Cys
residue within this domain (i.e. Cys15, Cys53 and Cys60 in STIM2 as opposed to Cys49 and Cys56
in STIM1). I found that mutating the additional modifiable Cys in STIM2 (i.e. Cys15Ser)
attenuated the GSNO-mediated thermodynamic stabilization of Ca2+ depleted single-mutant
STIM2 15-217 compared to wildtype protein (i.e. DDGH2O = +0.49 kcal/mol versus +1.16
kcal/mol). To my surprise, when only the unique Cys15 was available for modification (i.e.
Cys53Ser/Cys60Ser), S-nitrosylating conditions failed to thermodynamically stabilize the Ca2+
depleted double-mutant STIM2 15-217 protein. It is likely that, in conditions with excess NO,
Cys15 mediates an increase in protein thermodynamic stability which is dependent on Cys53 and
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Cys60, essentially serving as a supplemental modification site to further stabilize STIM2 15-217.
Alternatively, as observed for STIM1, it is possible that my in vitro stability assays lack the
sensitivity to detect differences and other analyses such as functional electrophysiological
experiments are required to reveal any differences with single mutant proteins. Nevertheless, my
study reveals that the supplemental post-translational modification site specific to the STIM2
paralog is modifiable and may contribute to differential regulation between STIM proteins
endogenously.
Having observed that excess NO mediates enhanced stability, the effects of GSNO treatment on
STIM2 full luminal domain oligomerization propensity and exposed hydrophobicity were also
explored using the same experimental techniques and parameters previously used to study the full
luminal domain of STIM1 in the presence of excess NO (Zhu et al., 2018). While excess NO
mediated clear de-oligomerization of the Ca2+ depleted STIM1 luminal domain concomitant with
a decrease in the level of solvent exposed hydrophobicity (Zhu et al., 2018), these phenomena were
not observed for the STIM2 luminal domain under similar conditions. My inability to detect an
effect of NO on these properties may be related to the much more modest changes in solvent
accessible hydrophobicity (i.e. ~4-fold enhancement in ANS fluorescence intensity for STIM1
compared to ~1.2-fold enhancement for STIM2) and oligomerization state (i.e. distribution of
hydrodynamic radii centered at ~10 nm for STIM1 compared to ~5 nm for STIM2) caused by Ca2+
depletion (Zhu et al., 2018).

4.4. Structural mechanism by which excess NO stabilizes the full luminal
domain of STIM2
Previous studies indicate that S-nitrosylation profoundly affects the structure of proteins. It has
been demonstrated that S-nitrosylation of the cytoplasmic rhodanese domain at Cys63 from the E.
coli membrane bound sulfur-transferase protein (YgaP) elicits structural alterations associated
with enhanced protein stability (Eichmann et al., 2016). Specifically, NMR spectroscopy
demonstrated that S-nitrosylation of rhodanese disrupts the electrostatically unstable interaction
between the C-terminal a5 helix and the active site, thus enhancing stability (Eichmann et al.,
2016). In a more recent study, spectroscopic techniques revealed that S-nitrosylation of galectin-2
(Gal-2) at Cys57 increases thermal stability concomitant with structural alterations (Sakakura et
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al., 2018). Similar to my thermal stability assessment, CD spectroscopy determined that Snitrosylation mediated an increase in protein thermal stability of Gal-2 by ~+5 °C compared to
unmodified protein (Sakakura et al., 2018). This enhanced thermal stability was mediated by Snitrosylation induced structural changes detected by NMR spectroscopy, wherein stabilization of
the hydrophobic pocket around Cys57 prevents oxidation induced destabilization (Sakakura et al.,
2018).
Likewise, I utilized solution NMR spectroscopy to characterize the structural changes associated
with STIM2 15-217 thermal and thermodynamic stabilization after GSNO treatment. The presence
of excess NO induced structural changes downstream of the variable N-terminal region, which
largely clustered on the entering helix of the canonical EF-hand and on the exiting helix of the
non-canonical EF-hand and the adjacent SAM linking helix (Fig. 3.5A and 3.5B). Mapping the
CSPs on the surface of the STIM2 EFSAM structure revealed that a majority of these residues are
localized to one face of the EFSAM core (Fig. 3.5D). These data indicate that the variable Nterminal region encompassing the three modifiable Cys sulfhydryls may be looping around to
interact with one face of the EFSAM core, which ultimately promotes enhanced thermodynamic
stability of the entire luminal domain (Fig 4.1A). The presence of excess NO may be either
mediating new interactions between these regions or changing the interactions between these
regions in some manner to facilitate the enhanced thermodynamic stability. Remarkably, the
STIM2 interface identified in my study using CSP mapping is the analogous to the interface
identified in NMR experiments of isolated STIM1 variable N-terminal peptides titrated into
solutions of EFSAM core proteins (Zhu et al., 2018).
Because excess NO thermodynamically stabilizes wildtype STIM2 15-217 to a larger degree
compared to Cys15Ser STIM2 15-217, it is likely that the loss of the Cys15 modifiable sulfhydryl
perturbs the interaction of this residue with the EFSAM core, mediating a relatively decreased
thermodynamic stability enhancement of single mutant STIM2 luminal domain protein in the
presence of excess NO (Fig. 4.1B). On the other hand, STIM2 15-217 protein with only the unique
Cys15 sulfhydryl available for S-nitrosylation (i.e. Cys53Ser/Cys60Ser double mutant protein)
appeared thermodynamically insensitive to excess GSNO treatment (Fig. 3.6.3G-I), suggesting
that the changes mediated by Cys15 are dependent on the interaction of Cys53 and Cys60 with the
EFSAM core in the presence of excess NO (Fig. 4.2C). When all modifiable Cys sulfhydryls were
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mutated (i.e. Cys15Ser/Cys53Ser/Cys60Ser triple mutant protein), excess GSNO treatment did not
affect thermodynamic stability (Fig. 3.6.3J-L), suggesting that the NO mediated structural
perturbations which enhance STIM2 luminal domain stability are Cys-specific (Fig. 4.2D).
It is interesting to note that STIM1 disulfide bond formation between Cys49 and Cys56
destabilizes this protein, thereby enhancing STIM1-mediated SOCE (Prins et al., 2011). The
luminal domain of STIM proteins are located within the moderately oxidizing environment of the
ER. As opposed to the cytosol, the ER contains a relatively higher ratio of oxidized glutathione
(i.e. GSSG) to reduced glutathione (i.e. GSH), which is conducive for protein disulfide bond
formation, required for nascent protein folding of numerous proteins. Perhaps the structural
perturbations demonstrated by excess GSNO treatment not only served to stabilize the full luminal
domain of STIM2, but also promoted a conformation which is unfavourable for disulfide bond
formation, thereby preventing potential STIM2 activation mediated by intramolecular luminal
disulfide bond formation.
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4.5. Implications of excess NO mediated STIM2 functional suppression in
health and disease
Given that the NO donor, GSNO, enhanced the thermodynamic stability of wildtype STIM2 15217, I anticipated that GSNO treatment of mammalian cells overexpressing full length STIM2 and
Orai1 would attenuate basal Ca2+ levels and SOCE. As expected, cells co-overexpressing full
length STIM2 and Orai1 showed enhanced basal, ER stored Ca2+ and SOCE compared to cells
expressing Orai1 and mCh in the absence of STIM2. Treating the STIM2/Orai1 co-overexpressing
cells with GSNO reduced the basal Ca2+ levels, TG-induced ER Ca2+ release and maximal Ca2+
uptake after extracellular Ca2+ addback (i.e. SOCE) back to levels observed in the cells without
STIM2

expression

(Fig.

3.8.1

and

3.8.2).

Surprisingly,

co-overexpressing

Cys15Ser/Cys53Ser/Cys60Ser STIM2 with Orai1 did not enhance resting or stimulated Ca2+
levels, despite the luminal domain destabilization caused by this triple mutation. To my
knowledge, this is the first example of a variation in either STIM2 or STIM1 that caused a
decreased luminal domain stability without promoting SOCE (Gui et al., 2018; Stathopulos et al.,
2008a; Zheng et al., 2008; Zhu et al., 2018). Given that the Cys15 is located immediately adjacent
to the ER signal peptide of STIM2, it is possible that the Cys15Ser variation prevented or perturbed
the ER localization of STIM2. Interestingly, past studies have found that a fraction of wild-type
STIM2 escapes ER targeting and accumulates in the cytosol (Graham et al., 2011). Thus, the
Cys15Ser mutations may alter the ER versus cytosolic accumulation levels.
STIM2 functions not only to elicit agonist-induced SOCE, but also acts as a basal Ca2+ homeostatic
feedback regulator (Brandman et al., 2007). Therefore, alternations to STIM2 function in cells
have the potential to play roles in diseases with dysregulated Ca2+ homeostasis. While there are
currently no identified pathologies caused by single mutations to human STIM2 alleles,
upregulated and hyperactivated STIM2 has been linked to numerous pathological conditions,
especially within the nervous system. Mice models established that in the presence of STIM2,
neuronal damage under transient anoxic conditions is amplified (Berna-Erro et al., 2009).
Moreover, mouse neurons deficient in STIM2, but not STIM1, demonstrated an enhanced
resistance to Ca2+ dependent apoptosis induced by anoxic conditions, possibly by preventing
cytosolic Ca2+ overload (Berna-Erro et al., 2009). Similarly, traumatic brain injury upregulated
STIM2 expression in mice neurons, and selective knockdown of STIM2, but not STIM1, improved

96

neuronal survival after this pathology (Rao et al., 2015), likely due to restoring Ca2+ homeostasis
within these neurons. In medium spiny neurons (MSN) isolated from mouse models of
Huntington’s disease (i.e. YAC128 MSNs), hyperactive STIM2 mediates sustained and cytotoxic
SOCE (Wu et al., 2016). Knockout of STIM2 rescued spine loss in YAC128 MSNs by restoring
dysregulated Ca2+ homeostasis (Wu et al., 2016).
Within the vascular system, STIM2 expression was shown to be upregulated in pulmonary arterial
smooth muscle cells (PASMCs) from patients with pulmonary arterial hypertension (PAH) (Song
et al., 2011). STIM2, together with Orai2, increases cytosolic Ca2+ levels which triggers the
transition of contractile PASMCs to the proliferative phenotype, thus contributing to PAH
(Fernandez et al., 2015). The pathological molecular mechanism was later discovered, whereby
upregulated STIM2 in PAH-PASMCs elevates basal Ca2+ levels to activate the CREB, STAT3,
AKT, NFAT and Bcl-2 signalling pathways, which ultimately stimulate proliferation and inhibit
apoptosis (Song et al., 2018). It is possible that excess NO-mediated STIM2 inhibition could
ameliorate these conditions with hyperactive or upregulated STIM2, and that endogenous NO
production could act as a protective mechanism by maintaining STIM2 in a quiescent state through
S-nitrosylation mediated stabilization of the luminal domain.

4.6. Future directions and limitations
In my current study, I revealed the structural mechanism by which the excess NO donor, GSNO,
thermally and thermodynamically stabilized the full luminal domain of STIM2, which suppressed
function in the full-length molecular context. Furthermore, compared to STIM1, I revealed an
additional modifiable Cys residue within the variable N-terminal region of STIM2, which
supplements the enhanced stabilization mediated by the Cys residues conserved with STIM1 in
the presence of excess NO. While my NMR data identified regions within the EFSAM core that
were structurally perturbed in the presence of excess NO, solving the 3D structure of the EFSAM
core in the modified state(s) would reveal precisely how the tertiary structure and fold of EFSAM
changes in response to this modification. Nevertheless, S-nitrosylation is an exceptionally labile
modification, making these studies difficult. Upon ER Ca2+ depletion, STIM2 co-localizes with
Orai1 in ER-PM junctions to mediate SOCE. Therefore, cell microscopy studies clarifying whether
GSNO treatment disrupts this STIM2:Orai1 co-localization in mammalian cells would
complement my Ca2+ assessments and reveal whether the Cys mutations alter the localization of
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STIM2. Previous studies indicate that STIM proteins are able to undergo a plethora of posttranslational modifications that can either activate or inactivate the molecule. Understanding the
precise biological environments which promotes specific post-translational modifications that
affect STIM function would further refine our understanding on how STIM proteins are regulated.
The work described in this thesis represents the first study to my knowledge that reports the effects
of GSNO treatment on STIM2 function. However, my work focuses only on mechanism in the
physiological context. Because upregulated and hyperactive STIM2 underlie the pathogenesis of
multiple diseases (see above), investigating whether NO can affect these conditions in vitro and/or
in vivo would greatly enhance our understanding of these diseases in the pathological context and
potentially reveal new treatment avenues.
There are some notable limitations within this present study. First, during expression and
purification procedures, human proteins expressed in bacteria were denatured and subsequently
refolded outside their native environment; thus, the proteins may not have adopted a true native
state. Second, my in vitro biophysical characterization studies used isolated STIM2 protein
fragments, which does not fully recapitulate the ER-tethered environment of most STIM2
molecules. Third, all experiments were performed using and maintaining high levels of the NO
donor, GSNO, due to the labile nature of protein S-nitrosylation, which limited the types of
investigations that could be conducted. Specifically, Ca2+ binding affinity via CD spectroscopy
was not assessed due to the marked increase in high tension associated with GSNO-containing
buffers. Moreover, direct mass spectrometry measurements to unequivocally detect the protein Snitrosylation was not possible. Fourth, my full-length STIM2 protein harbouring the Cys mutations
could not be used to confirm the Cys-dependence of the NO-mediated suppression of basal and
stimulated cytosolic Ca2+ due to the inability of the triple mutant to enhance SOCE and the wildly
variable responses observed with the single Cys15Ser mutant.
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4.7. Conclusions
Calcium signalling is ubiquitous and involved in a wide range of physiological processes such as
apoptosis, muscle contraction and gene transcription. In order to tightly regulate these processes,
Ca2+ is effectively segregated in intracellular stores, most notably within the ER. STIM2 is an ER
resident Ca2+ sensing protein which, together with the PM Orai1-composed Ca2+ channels,
responds to ER Ca2+ levels in order to regulate cytosolic Ca2+. Under ER Ca2+ store replete
conditions STIM2 regulates basal Ca2+ levels. Upon ER Ca2+ store depletion due to a cellular
stimulus, STIM2 mediates SOCE. Hence, modifications influencing STIM2 activity can influence
both resting and stimulated Ca2+ levels within cells.
Post-translational modifications profoundly impact protein structure and function, which underlie
important biological roles, such as cellular trafficking, signalling cascades, and protein activation
and localization. Perhaps the most commonly studied post-translational modification is protein
phosphorylation; however, until recently, few studies have examined the role of S-nitrosylation,
which is the covalent attachment of a NO moiety to a sulfhydryl. Recently, S-nitrosylation has
been demonstrated to reduce the activity of STIM1, but knowledge on how this modification may
affect STIM2 function was completely lacking.
Therefore, this thesis investigated the biophysical, structural and functional consequences that Snitrosylation has on the Ca2+ sensing luminal domain of STIM2 to enhance our understanding of
Orai1 Ca2+ channel regulation. Biophysically, my data reveal that excess NO donor stabilizes the
full luminal domain of STIM2 in a Cys-specific manner, whereby a unique Cys residue present in
the Ca2+ sensing region of STIM2 but not STIM1, is involved in the stabilization. Structurally, the
presence of excess NO induces changes to the full luminal domain of STIM2 which were
predominantly localized to one face of the EFSAM core. Functionally, GSNO treatment of
mammalian cells co-overexpressing wildtype mChSTIM2 and eGFP-Orai1 attenuated basal Ca2+
levels, decreased ER stored Ca2+ levels as well as SOCE (Fig. 4.2).
In conclusion, my thesis not only advances our biophysical, structural, and functional knowledge
of the effects excess NO has on STIM2-mediated Ca2+ flux (Table 4.1), but also brings us to the
forefront of the field with new and important questions that must be answered in order to fully
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understand STIM2 function and the role of S-nitrosylation in regulating its structure and function
in health and disease. NO has long been known to confer physiological benefits, including
stimulation of oxygen and blood flow, reduction of blood pressure, and boosted endurance;
however, my research demonstrates a novel mechanism by which NO can regulate STIM2mediated Ca2+ homeostasis.

Table 4.1. Summary of GSNO mediated effects on various properties associated with STIM2

Thermal stability b
Oligomerization

b

Exposed hydrophobicity b
Thermodynamic stability b
Basal Ca2+ levels c
SOCE activation c

Reducing conditions
(1 mM DTT; -S-H)a

S-nitrosylating conditions
(1 mM GSNO; -S-N=O)a

¯
¯





¯
¯

(¯) Relatively lower, () Relatively higher, (-) No apparent change
a

properties of 1 mM DTT treatment compared to 1 mM GSNO treatment

b

experiments using recombinant human STIM2 15-217 protein

c

experiments using HEK293T cells co-overexpressing mChSTIM2 variants and eGFP-Orai1
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